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P-1: Gender and Cue-Induced Imaging in 
Nicotine Dependence
Karen Hartwell (presenting author),1 Kevin Johnson,2
Hugh Myrick,1 and Kathleen Brady1
Departments of 1Psychiatry and Behavioral Sciences, and
2Neurosciences, Medical University of South Carolina
Background: Tobacco dependence remains a significant pub-
lic health concern. In the United States, cigarette smoking
continues to be the leading preventable cause of mortality,
accounting for about one out of every five deaths. Exposure
to cues associated with smoking results in behavioral, phys-
iological, and subjective effects, including craving. Smoking-
related craving can precipitate smoking in abstinent smok-
ers. There appear to be important gender differences in
smoking behavior and response to nicotine.
Objective: This pilot study is designed to increase under-
standing of the neural circuitry underlying nicotine cue-in-
duced craving and to examine possible gender differences.
Method: Nontreatment-seeking nicotine-dependent indi-
viduals (five males & five females) and healthy controls (five
males & five females) participated in functional magnetic res-
onance imaging (fMRI) with the presentation of smoking-re-
lated cues. Smoking subjects were asked to be abstinent 12
hours before the scanning session. Subjects were assessed for
craving, nicotine withdrawal, and CO levels.
Results: Preliminary data suggest activation in the ACC,
NA, & amygdala with cue presentation in smokers, but not
in healthy controls.
Conclusion: Given the aforementioned differences in brain
activity between smokers and healthy controls, the role of
gender in activation patterns will also be explored.
P-2: Potentiation of Cue-Induced Reinstatement of
Cocaine-Seeking in Female Rats by Yohimbine
Matthew Feltenstein (presenting author), Michele
Bongiovanni, Alisha Henderson, Elizabeth Byrd, 
and Ronald See
Department of Neurosciences, Medical University 
of South Carolina
Background and Objective: Clinical research suggests that gen-
der differences exist in cocaine dependence. Similarly, female
rats exhibit higher responding during cocaine self-adminis-
tration and enhanced cocaine-primed reinstatement of drug-
seeking. However, limited data exist regarding sex differences
in reinstatement following exposure to stress or drug-associ-
ated cues, two factors that trigger drug craving and relapse
in abstinent cocaine users. Thus, we examined the impact of
the anxiogenic a2-noradrenergic receptor antagonist, yohim-
bine, on reinstatement of cocaine-seeking in rats either in the
presence or absence of cocaine-associated cues.
Method: Rats lever-pressed for intravenous cocaine paired
with the presentation of a lighttone stimulus for 10 days.
Responding was then extinguished in the absence of cocaine
or cues. Thirty minutes prior to reinstatement of cocaine-
seeking either in the presence or absence of the cocaine-
paired stimulus, rats received an injection of yohimbine (0,
1.25 or 2.5 mg/kg).
Results: Yohimbine alone resulted in reinstatement of co-
caine-seeking behavior, an effect that was significantly
greater in female rats. While cues alone produced compara-
ble cocaine-seeking in both males and females, yohimbine
pretreatment in combination with the cues resulted in a
supra-additive effect in both groups, with females demon-
strating greater yohimbinecues reinstatement.
Conclusion: While there were no sex differences in response
to drug-paired cues, exposure to a stressor alone, or in com-
bination with cocaine-associated cues, resulted in greater re-
instatement in female rats. Overall, these results suggest that
stress enhances the saliency of drug-associated cues and that
the impact of stress activation on drug-paired stimuli may
potentiate relapse risk in abstinent cocaine users, particularly
females.
P-3: PFIQ Scores Improve after Prolapse Surgery 
in Women With Depressive Symptoms but 
Remain Higher than in Women Without
Depressive Symptoms
Chiara Ghetti (presenting author), Jerry Lowder, Rennique
Ellison, Marijane A. Krohn, and Pamela Moalli
Department of Obstetrics, Gynecology, and Reproductive
Sciences, University of Pittsburgh
Background: Little is known about depressive symptoms in
women with pelvic organ prolapse (POP).
Objective: To compare pelvic floor-related QOL scores fol-
lowing reconstructive surgery in women with and without
depressive symptoms at baseline.
Method: This is an IRB-approved prospective cohort study
of 75 women with stage II POP planning surgery designed
to assess impact of POP on body image. Subjects were en-
rolled from a urogynecology practice and completed self-ad-
ministered measures at baseline and 6 months postopera-
tively. Measures included the Pelvic Floor Distress Inventory
(PFDI), Pelvic Floor Impact Questionnaire (PFIQ), and Pa-
tient Health Questionnaire-9 (PHQ-9). PHQ-9 is a validated
measure of depression severity. Total scores of 10 correlate
with moderate to severe depressive symptoms. Mean values
and 95% confidence intervals were determined for the PFDI,
PFIQ, and change in scores.
Results: Complete data were available for 58 women. Sub-
jects had mean age 60  8 years, mean BMI 28  5 kg/m2,
were predominantly Caucasian (96%) and postmenopausal
(82%); a majority had stage III prolapse (83%). At baseline,
23% had moderate to severe depressive symptoms, 77% had
none to minimal symptoms. Women with depressive symp-
toms had higher PFIQ scores compared to women without
symptoms at baseline. Women with depressive symptoms
had elevated PFIQ compared to women without depressive
symptoms.
Conclusion: Pelvic floor disorders appear to have a greater
impact on women with depressive symptoms as measured
by PFIQ before and after surgery. The relationship between
depression, quality of life, and pelvic floor symptoms needs
further study to understand the true impact of POP on
women.
P-4: Feasibility of a School-Based Coping
Intervention for Latino Adolescent Girls
Carolyn Garcia
School of Nursing, University of Minnesota
Background: Latino girls (Latinas) experience higher rates of
depression and suicidal ideation than other girls their age
and Latino boys. Latina adolescents may benefit from pre-
ventive interventions that improve their ability to respond
to and cope with life stressors. A coping intervention
grounded in the knowledge about healthy youth develop-
ment was developed for Latina adolescents.
Objective: To evaluate the feasibility and acceptability of a
school-based coping intervention for Latina adolescents.
Method: Latina adolescents, 15–21 years old, were recruited
from two schools to participate in a 14-week coping inter-
vention. Participants met weekly for a 2-hour program,
facilitated by two bilingual staff, consisting of dialogue, ex-
ercise, and skills-building. To assess feasibility and accept-
ability, weekly participation and attendance and post-inter-
vention focus group data were analyzed.
Results: Twenty-one Latina adolescents were successfully
recruited. The fall semester intervention (n10) occurred
during school and had a 72% attendance rate; the spring se-
mester intervention (n11) was held after school and had an
84% attendance rate. Nine of the 21 (42%) participants at-
tended all sessions. Three (14%) attended fewer than half of
the sessions and unofficially dropped out. Three participants
had limited involvement due to deportation issues involv-
ing themselves or a family member. Focus group data dem-
onstrate participant acceptability, “I liked the discussions”
and skills gained, “like coping skills to control stress. So
when you learn ways to lessen your stress, then you learn
to make your life a little easier.”
Conclusion: The intervention appears feasible and accept-
able. A randomized controlled trial is warranted to examine
intervention effectiveness.
P-5: Postpartum Mental Health After 
Hurricane Katrina
Emily Harville (presenting author),1 Xu Xiong,1 Gabriella
Pridjian,1 Karen Elkind-Hirsch,2 Pierre Buekens1
1Tulane University and 2Woman’s Health Research Institute—
Woman’s Hospital
Background: Natural disaster is often a cause of psy-
chopathology and women are more vulnerable to posttrau-
matic stress disorder (PTSD) and depression. Postpartum de-
pression is also common. However, no research has
addressed postpartum women’s mental health after a nat-
ural disaster.
Objective: To examine the prevalence and correlates of de-
pression and PTSD among postpartum women affected by
Hurricane Katrina.
Method: Two hundred eighty-nine (289) New Orleans and
Baton Rouge women were interviewed at 8 weeks postpar-
tum, and 214 at 1 year. PTSD was assessed using the Post-
Traumatic Stress Checklist (PCL) and depression using the
Edinburgh Depression Scale. Women were asked about their
experience with the hurricane with several questions ad-
dressing threat, illness, loss, and damage. Chi-square tests
and log-binomial/Poisson models were used to calculate as-
sociations and relative risks (RR) for hurricane experience
and demographics.
Results: Nineteen percent (19%) of women met the criteria
for depression and 13% for PTSD. Feeling that one’s life was
in danger during the storm was strongly associated with de-
pression and PTSD, as were having a family member have
an illness or injury, walking through floodwater, and severe
impact on property. Overall, two or more experiences of the
storm were associated with an increased risk for both de-
pression (RR 1.71, 1.05–2.78) and PTSD (RR 3.49, 1.71–7.12).
Conclusion: Postpartum women who severely experience
natural disaster are at increased risk for mental health prob-
lems, but overall rates of depression and PTSD are not higher
than for the general population.
P-6: Cognitive-Behavioral Therapy for Physical and
Emotional Disturbances in Adolescents with
Polycystic Ovary Syndrome: A Pilot Study
Dana L. Rofey (presenting author),1,2 Eva M. Szigethy,1,2
Robert B. Noll,1,2 Ronald E. Dahl,1,2 Emily Iobst,1 and
Silva A. Arslanian1
1Children’s Hospital of Pittsburgh and 2Western Psychiatric
Institute and Clinic, University of Pittsburgh School of
Medicine
Background: Polycystic Ovary Syndrome (PCOS) is the most
common endocrinopathy affecting women in the reproduc-
tive group, with prevalence rates of 5–12%. Hormonal im-
balances in PCOS induce oligoovulation, which is associated
with irregular menstruation, hirsutism, and acne. The nu-
merous devastating clinical symptoms of PCOS and associ-
ated comorbidities place adolescents with this disorder at an
increased risk for physical (obesity) and emotional (depres-
sion) disturbances.
Objective: To evaluate the feasibility and effectiveness of
an enhanced cognitive-behavioral therapy, Primary and Sec-
ondary Control Enhancement Training (PASCET-PI-2), for
obesity and depression in adolescents with PCOS.
Method: In an open trial, 12 adolescents (12–18 years, En-
glish-speaking, 58% Caucasian, 25% African American) with
PCOS, obesity, and depression underwent 8 weekly sessions
and 3 family-based sessions of CBT enhanced by lifestyle
goals (nutrition and exercise), physical illness narrative
(meaning of having PCOS), and family psychoeducation
(family functioning).
Results: Weight on calibrated SECA scales showed a sig-
nificant decrease across the eight sessions from an average
of 104 kg (SD26) to an average of 93 kg (SD18), t(11) 
6.6, p.05. Depressive symptoms on the Children’s Depres-
sion Inventory significantly decreased from a mean of 17
(SD3) to a mean of 9.6 (SD2), t(11)16.8, p.01.
Conclusion: A manual-based CBT approach to treat de-
pression in adolescents with PCOS and obesity appears
promising. This investigation utilizes a novel paradigm that
incorporates ecological momentary assessment (EMA—
wearable monitors that document energy and calorie ex-
penditure and frequent mood-monitoring phone calls) that
addresses the shared psychological, behavioral, and biolog-
ical pathways for physically ill youth.
P-7: The Gender Specification and Cultural
Sensitivity of Depression Research With Black
Americans: A Multidimensional Model
Daphne C. Watkins (presenting author) and Timothy 
R. B. Johnson
Department of Obstetrics and Gynecology, University 
of Michigan
Background: Gender differences in depressive disorders are
influenced by gender roles and response styles to depressed
mood. Yet, a comprehensive understanding of (1) the dif-
ferences influenced by the intersection of gender, ethnicity,
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and culture and (2) the epidemiology, etiology, and risk fac-
tors for depressive mood is still needed. For instance, preva-
lence rates of depressive disorders among black Americans
are not clear. While being a woman increases risk for de-
pression, being black does not. Data suggest that black
women do not experience depression at higher rates than
white women, but they experience depression more often
than black men.
Objective: This research (1) highlights findings from an ag-
gregation of scientific knowledge on the influence of gender,
ethnicity, and culture on depression in black Americans and
(2) presents a multidimensional model of gender specifica-
tion and cultural sensitivity of depression research on black
Americans.
Method: Our objectives were achieved by synthesizing the
available research on depressive mood in black Americans
and testing the applicability of a multidimensional frame-
work for guiding this research.
Results: Compared to whites, black men and women re-
port greater psychiatric comorbidity, increased severity of
somatic symptoms, greater life stress, and differences in per-
ceived physical functioning and health beliefs, which di-
rectly influence the presentation of depressive mood.
Conclusion: Before successful mental health interventions
can be considered for black Americans and efforts made to-
ward prevention, the development of culturally sensitive
and gender-specific programs that achieve optimal mental
health are needed.
P-8: Developmental and Situational Crises of Late
Adolescence/Early Adulthood in Military Couples
With Life-Threatening Fetal Anomalies
Beth Perry Black
Family Health Department, School of Nursing, University of
North Carolina at Chapel Hill
Background: Diagnosis of a life-threatening fetal anomaly
constitutes a crisis for pregnant women and their partners
who face a difficult decision whether to continue pregnancy.
Younger couples face this diagnosis and decisions drawing
on limited life experience. Young military couples may be
particularly vulnerable to distress in this major adult crisis
while still mediating the developmental tasks of late ado-
lescence and early adulthood.
Objective: The purpose of this research is to describe young
military couples’ decisionmaking and the aftermath in this
situational crisis in the context of limited adult development.
Method: Data for this case-intensive ethnography were col-
lected through longitudinal narrative interviews and pho-
tography of pregnancy and infant memorabilia. Data from
three military couples in the larger study, ages 19–21, were
purposefully selected for directed content analysis, framed
by extant developmental and situational crisis theories.
Results: In context of early marriage, unplanned preg-
nancy, separation from family, and deployment or the threat
of deployment, couples faced this crisis with little prepara-
tion to manage its complexities. Participants described their
isolation, shock, and despair; later reactions included anger,
hopefulness, and creating meaning of the life of the fe-
tus/baby. Wives continuing pregnancy established elaborate
memorials; the couple electing termination wanted little in-
formation. Husbands focused on wives’ emotional well-be-
ing but admitted little understanding; wives described a pro-
found sense of failure and guilt.
Conclusion: When planning and providing care and sup-
port to young military couples, healthcare providers should
consider the particular complexities of their lives and lim-
ited adult development.
P-9: Physical Activity, Menopause, and Quality of
Life: The Role of Affect and Self-Worth 
Across Time
Steriani Elavsky
Department of Kinesiology, The Pennsylvania State University
Background: Physical activity has been shown to enhance
quality of life; however, few investigations of these effects
exist in women undergoing the menopausal transition.
Objective: The present study examined the long-term ef-
fects of physical activity on menopause-related quality of life
(QOL) and tested the mediating effects of physical self-worth
(i.e., self-esteem specific to the physical domain) and posi-
tive affect in this relationship.
Method: Middle-aged women (N  164, M age  49.9,
SD  3.6) previously enrolled in a 4-month randomized con-
trolled trial involving walking, yoga, and a control group
completed a followup mail-in survey 2 years following the
end of the trial. The survey included a battery of psycho-
logical and physical activity measures, including measures
of menopausal symptoms and menopause-related quality of
life. Longitudinal linear panel analysis was conducted within
the covariance modeling framework.
Results: At the end of the trial, physical activity and meno-
pausal symptoms were related to physical self-worth and
positive affect, and in turn, greater levels of physical self-
worth and positive affect were associated with higher levels
of menopause-related QOL. Analyses indicated that changes
in physical activity and menopausal symptoms over the 2-
year period were related to increases in physical self-worth
and for symptoms also to positive affect; both physical self-
worth and affect directly influenced changes in QOL.
Conclusion: The findings support the position that physi-
cal activity effects on QOL are in part mediated by interme-
diate psychological outcomes and that physical activity can
have long-term benefits for women undergoing the meno-
pausal transition.
P-10: Sex Differences in Depression: Roles 
for Gonadol Hormones and the 
Developing Hippocampus
Jian-Min Zhang (presenting author),1 and 
Margaret M. McCarthy1,2
Departments of 1Psychiatry and 2Physiology, School of
Medicine, University of Maryland, Baltimore County
Background and Objective: Women are twice as likely as men
to have major depression. Evidence suggests that gonadol
hormones play a role in the gender difference of major de-
pression. However, mechanisms of hormonal effects in de-
pression remain unclear. The hippocampus is an effector or-
gan for gonadol hormones during development because both
estradiol and testosterone and their receptors are present in
perinatal stages. The hippocampus is also a key structure in
the pathology of depression. We want to know whether the
effects of gonadol hormones on perinatal hippocampal de-
velopment play a role in depression that develops later in
life.
Method: Rat pups were treated with hormones (estradiol,
testosterone, dihydrotestosterone (DHT), flutamide, or vehi-
cle) on postnatal day (PND) 0 and 1, and with 5-bromo-2-
deoxyuridine-5-monophosphate (BrdU) on PND 1, 2, 3 and
4, respectively. Newly produced cells were labeled with
BrdU incorroperation; glial cells were identified with anti-
body against glial fibrillary acidic protein (GFAP). Newly
produced glial cells were double-labeled with antibodies
against BrdU and GFAP.
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Results: (1) Male neonates have significantly more BrdU
cells than females in the CA1 and dentate gyrus (DG) re-
gions of the hippocampus. Both estradiol- and androgens
(testosterone and DHT)-treated females have significantly
more BrdU cells than vehicle-treated females have in the
hippocampus. (2) Male neonates have more GFAP cells in
the CA1 region than females have; whereas estradiol-treated
and testosterone-treated, but not DHT-treated, female
neonates, mimicking male neonates, have more GFAP
cells.
Conclusion: Both estrogen and androgens promote cell gen-
esis in the developing hippocampus, and the estrogen but
not androgen may promote gliogenesis.
P-11: An Understanding of the Sex Differences
Among Preteen Adolescents at High Risk of HIV
and Substance Abuse
Donna M. DeFreitas (presenting author),1
Catrina D. Virata,1 Christiana Drake,3 N. Greene,1
and Edward J. Callahan2
Departments of 1Medicine, 2Family Practice, and 3Statistics,
University of California, Davis
Background: This team showed that preteen girls may use
condoms less than male peers. The objective of this study
was to determine if there were other sex-based differences
between youth at risk of HIV.
Method: We evaluated racially diverse youth from low-in-
come locations in Northern California who were concur-
rently enrolled in an HIV-prevention project. Detailed sur-
veys were used to collect data on household information;
youth described behavior involving sex, drug use, and HIV
knowledge.
Results: Preteen girls (n113) showed more self-efficacy
for increased condom use, decreases in alcohol use with sex,
and resistance to sexual pressure compared with preteen
boys (n114) in a sexual risk assessment scale (9.7 vs. 11.1,
p0.05); girls and boys have the same perception of indi-
vidual HIV risk score (2.3 vs. 2.4, p ns), and HIV knowl-
edge scores were the same in both groups. (p ns). In mod-
els predicting sexual behavior, boys consistently had more
sexual activity than girls, even correcting for age, religious
conviction, living condition, and drug use AOR: 1.79 (CI; 95%
1.47–2.18). After adjusting for age, religious belief, sexual ac-
tivity experience, HIV knowledge, and living situation, pre-
teen boys and girls used condoms the same amount,
AOR:0.91 (CI 95% .66–1.27).
Conclusion: Preteen girls in northern California have more
confidence in their real world ability to limit high-risk be-
havior compared to boys, but tend to have very similar risk
behavior. These findings suggest an increased need to focus
on behavior rather than intent to decrease HIV acquisition
in youth.
P-12: Acceptance of Human Papillomavirus (HPV)
Vaccination by Low-Income, Minority Parents
Rebecca B. Perkins (presenting author),1 Natalie 
Pierre-Joseph,1 Cecilia Marquez,1 Sandra Iloka,2 and 
Jack A. Clark2
1Boston University School of Medicine and 2Boston University
School of Public Health
Background: Cervical cancer is more common among low-in-
come and minority women. HPV vaccination has the poten-
tial to reduce healthcare disparities if widely utilized.
Objective: To characterize attitudes toward HPV vaccina-
tion in low-income, minority parents.
Method: Parents of vaccine-eligible girls were interviewed
before preventive health visits. Interviews assessed knowl-
edge of vaccine-preventable diseases, attitudes toward HPV
vaccination, and intention to vaccinate. Actual vaccination
rates were determined by chart review.
Results: Seventy-six (76) parents (93% female) participated:
32 African-American, 21 Latino, 21 Caucasian, and 2 other
races. Mean age was 43, and mean education level was 13
years. Eighty-two percent (82%) expressed a religious affilia-
tion; 50% were foreign-born, and 65% spoke English as their
primary language. Parents answered 49–66% of questions cor-
rectly about vaccine-preventable diseases. Knowledge scores
were similar across ethnic groups, and were similar for HPV
and other vaccine-preventable diseases: varicella, Hepatitis B,
and pertussis. Qualitative data indicated that parents believed
teenagers experimented sexually against parental advice and
saw HPV vaccination as a way of protecting their children
against sexually transmitted diseases and cancer. However,
they were concerned that vaccination could invite earlier or
unsafe sexual activity or have unknown side effects. Ninety-
one percent (91%) of parents supported HPV vaccination for
their daughters. Acceptance did not vary by ethnicity. Rea-
sons for declining included wanting more information, feel-
ing vaccination was unnecessary, religion, and side effects.
However, only 70% of girls received vaccination. Physicians
failed to offer vaccination to the remaining girls.
Conclusion: Low-income and minority parents have high
rates of HPV vaccine acceptance and physicians may not be
meeting parental demands.
P-13: Type-Specific Concordance Among
Monogamous Couples in Whom the Woman Had a
Recently Detected, Incident HPV Type
Lea E. Widdice (presenting author),1 Sepideh Farhat,2
Janet Jonte,2 David Breland,2 Yifei Ma,2 Cheryl Godwin 
de Medina,2 Evelyn Hanson,2 Julie Jay,2 Susanna 
Miller-Benningfield,2 Jen Simington,2 and 
Anna-Barbara Moscicki2
1University of Cincinnati and 2University of California, 
San Francisco
Background: HPV concordance between couples is low de-
spite sexual transmission.
Objective: To examine concordance between monogamous
couples in which the woman had a recent, incident HPV
type.
Method: Women participating in a longitudinal study be-
ing tested every 4 months for HPV were recruited for par-
ticipation with their monogamous male partner if they had
an incident, cervical HPV type at their most recent visit. Sites
tested were: oral, palm, and anogenital area. HPV-DNA PCR
used PGMY09/11 primers (Roche Molecular Systems).
Results: Twenty-five (25) couples were enrolled; 94% of
samples were adequate. Five couples had only one partner
with HPV. In three couples, neither partner had HPV. HPV
was detected in both partners in 17 couples. Of these, four
couples had no type-specific concordance. Thirteen had
type-specific concordance. All 13 had type-specific concor-
dance at anogenital sites, three had type-specific palmar con-
cordance, one had oral concordance. Four had type-specific
concordance for all types detected in the anogenital area.
Nine had type-specific discordance in addition to type-spe-
cific concordance in the anogenital area. Two couples in
whom a type was detected in the anogenital area of one part-
ner but not the other had the type detected in the mouth or
hand of the anogenital-negative partner.
Conclusion: Type-specific HPV concordance in monoga-
mous couples is common in the anogenital area, specifically
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in women with recent, incident HPV detected. Although the
palm and mouth were uncommon sources for infections,
when anogenital type-specific discordance occurs, the dis-
cordant type may be found in nongenital areas of the anogen-
ital negative partner.
P-14: HPV Risk Association in Urban Populations
Niharika Khanna (presenting author),1 S. Arnold,1 W.
Wong,2 M. Arora,3 T. Nettles,1 S. Swann,1 and A. Joshi3
Departments of 1Family and Community Medicine, and
2Epidemiology and Preventive Medicine, University of
Maryland School of Medicine; and 3Department of
Bioinformatics, University of Maryland, Baltimore County
Background: HPV risk profiling from published HPV preva-
lence studies was used as the basis of the risk-association tool.
Objective: To identify HPV-associated risk factors.
Method: Design—Cross-sectional convenience sample of
200 adult women. Setting—Urban University of Maryland
Family Medicine clinic (UMFMC). Patients—IRB assurances
received. Adult women age 18 and over, English literacy. In-
strument—A multi-item scale to identify HPV-associated
risk factors including two demographic items, one item re-
garding HPV status by history, five items on medical and re-
productive history, five items on sexual history, and three
social history items. The tool was computerized and admin-
istered using tablet PCs.
Results: Two hundred (200) women completed the survey.
There were 47% women age 30; 10.6% were positive for
HPV by history, 16.2% had prior abnormal Pap smears, and
39.9% had prior sexually transmitted disease. Sexual debut
was 16 years in 43.4% and 21.2% had casual sexual part-
ners. HPV-positive women had significant association with
abnormal Pap smear (p-value 0.0001), STD (p-value 0.0018),
and with illicit drug use (p-value 0.0002).
Conclusion: HPV infection by history is associated with ab-
normal Pap smears, prior STD, and drug use. This tool has
the potential for use in risk stratification, linkage to health
education, and as an entry point into HPV vaccination, HPV
screening, and to clinical trials in HPV.
P-15: Gender-Specific Differences in the HIV
Release Mechanisms
Vasundhara Varthakavi (presenting author) and Ellen
Heimann-Nichols
Division of Infectious Diseases, Department of Pediatrics,
Vanderbilt University School of Medicine
Background: Women who transmit HIV have been reported
to have four times higher viral loads than those who do not.
In addition, women progress to AIDS at lower viral loads
and higher CD4 counts than do men, a characteristic that 
has significant implications for treatment of HIV-infected
women. The mechanisms underlying these differences in
HIV viral loads in men vs. women are not understood.
Objective: The goal of this study was to test whether dif-
ferences in the cellular mechanisms that influence HIV re-
lease account for the disparity in viral loads between the
genders. We have recently identified a cellular protein, cal-
cium-modulating cyclophilin ligand (CAML) that restricts
HIV release from human cells. We tested endogenous levels
of CAML in primary lymphocytes derived from age group-
matched women and men.
Method: The levels of expression of CAML were assayed
by Western blotting and real-time PCR.
Results: The results from Western blotting analysis indi-
cate significantly lower amounts (3–4 fold) cellular CAML in
younger women belonging to the 20–30 years age group
compared to that of males. Further, the levels of CAML pro-
tein in cells obtained from women also correlated with the
reduced CAML mRNA (CAMLN relative to Male 0.10
–0.25) as indicated by real-time PCR. In contrast, we did not
note gender-specific differences in the cellular levels of
CAML in the subjects belonging to the 45–50 years age
group.
Conclusion: These data suggest that CAML levels dictate
the differences in viral loads, especially in the younger
women, and thereby might influence the dynamics of HIV
transmission.
P-16: A Teen Clinic Intervention To Reduce
Partner Violence Among Adolescent Females: 
A Feasibility Study
Elizabeth Miller
Department of Pediatrics, University of California, Davis
Background and Objective: One in five female high school stu-
dents report experiencing physical and/or sexual violence
from a dating partner, and these experiences are highly cor-
related with poor health outcomes. Barriers to case iden-
tification in the adolescent clinical setting include limited
adolescent care-seeking for partner violence, healthcare
provider discomfort, and lack of evidence-based interven-
tions to reduce adolescent partner violence. Our objective
was to obtain information from providers and school-based
clinic patients regarding a possible intervention to identify
and address adolescent partner violence in school health
centers.
Method: Qualitative interviews were conducted in a school-
based health center with nurse practitioners (N3) (trained
in the dating violence intervention) and patients (ages 14–17
years, N10) about the feasibility and potential utility of a
clinic-based intervention adapted for use in teen clinics. In-
terviews were transcribed, coded, and analyzed utilizing a
content-analysis approach. Specific attention was paid to
identifying themes related to implementing the intervention,
including concerns about effects on clinic flow (providers)
as well as confidentiality (patients).
Results: Preliminary findings from the nurse practitioner
interviews indicate a willingness to utilize the intervention
and concerns about time pressures and lack of resources to
assist patients. Patients were interested in receiving addi-
tional educational materials and discussing partner violence
in this clinical setting, but expressed specific concerns about
disclosure and confidentiality.
Conclusion: A brief clinic-based intervention adapted for
teen clinics appears to be acceptable for nurse practitioners
and patients. Whether this intervention is effective in chang-
ing adolescent knowledge and behaviors regarding partner
violence requires further testing.
P-17: A Conceptual Framework for Contraceptive
Decisions Based on Decision Support
Bryna Harwood (presenting author),1 Nadine Peacock,2
Alan Schwartz,3 and Stacie Geller1
1Department of Obstetrics and Gynecology, College of
Medicine; 2School of Public Health; and 3Department of
Medical Education, College of Medicine, University of Illinois
at Chicago
Background: The majority of unintended pregnancies in the
United States occur despite contraceptive use, which is a
function of contraceptive choices; less effective methods are
commonly used but highly effective methods are rarely so.
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Improving contraceptive decisions would decrease the un-
intended pregnancy rate.
Objective: Apply the Ottawa Decisional Support Frame-
work (ODSF) to contraceptive decisions using known factors
that influence contraceptive decisions in preparation for a
qualitative study.
Method: We reviewed the literature to identify factors that
influence contraceptive decisions. We applied the ODSF to
these factors to assess the determinants of the decision. ODSF
is appropriate for health decisions that are value-laden and
do not have a clear best choice.
Results: The literature review for contraceptive preferences,
attitudes, and use revealed 17 studies of adult U.S. women
published from 1970 to 2008. Characteristics of women, meth-
ods, and healthcare providers were identified as factors re-
lated to contraceptive choice or use. The characteristics
mapped to three of four determinants of decisions: resources
to make a decision (personal and external support), charac-
teristics (client and practitioner), and perception of decision.
Two important themes within perception of decision were
not explored in any study: conflict and stage of decision mak-
ing. No factors mapped to the fourth, perception of others.
Conclusion: Optimizing contraceptive decisionmaking is
crucial to reducing unintended pregnancies. The ODSF can
inform the development of decision support tools to opti-
mize contraceptive decisions. Future work will explore un-
examined themes related to perceptions of others and per-
ceptions of the decision to assess the determinants of the
contraceptive decision.
P-18: Over-Expression of Secreted Frizzled-Related
Protein 1 Inhibits Bone Formation and Attenuates
PTH Bone Anabolic Effects
Wei Yao (presenting author), Zhiqiang Cheng, Aaron
Pham, Cheryl Busse, and Nancy E. Lane
University of California, Davis
Background and Objective: Secreted frizzled-related protein 1
(sFRP1) is a soluble antagonist of the Wnt signaling path-
way. In this study, we investigated how over-expression of
sFRP1 (sFRP1-Tg) would affect bone formation and its in-
teraction with PTH treatment.
Method: Three-month-old WT or sFRP1-Tg male and fe-
male mice (n7–12/group) were treated with PTH (1–34)
(40g/d, 5x/wk) or Vehicle for 2 weeks. We monitored bone
architectural and bone turnover changes by microCT, bone
markers, and histomorphometry. Osteoblastic and osteoclast
maturation and function were accessed by primary bone
marrow stromal cell and osteoclast cultures.
Results: Males, but not females, had lower trabecular bone
mass (-32%). Genes associated with osteoblast maturation
(Runx2, SP7) and function (Bgalp), serum osteocalcin, min-
eral apposition rate (MAR), and bone formation rate (BFR)
were significantly decreased in sFRP1-Tg mice from both
genders. Bone resorption, measured by serum CTX-1, and
osteoclast surface were similar between sFRP1-Tg and WT
in vivo but was higher in sFRP1-Tg in vitro. Human PTH
(1–34) treatment for 2 weeks increased trabecular bone vol-
ume (female, 156% and male 319%) in WT mice as com-
pared to 84% in female and 103% in male sFRP1-Tg mice
(p  0.05 for PTH x genotype). Percentage increases in MAR
and BFR were lower in PTH-treated sFRP1-Tg mice than the
PTH-treated WT mice.
Conclusion: Over-expression of sFRP1 inhibited osteoblast
maturation and function and attenuated PTHs anabolic ac-
tion on bone. Gender differences in bone phenotype of the
sFRP1-Tg animal and gender-specific response to PTH are
being investigated.
P-19: Genetic Variants in the Transforming
Growth Factor- (TGF-) Signaling Axis in
Patients with Scleroderma
Monique Hinchcliff (presenting author),1 Chiang-Ching
Huang,2 Maureen Sadim,3 Deena Raval,4 John Varga,1
Boris Pasche3
1Division of Rheumatology, Department of Medicine; 2Division
of Hematology/Oncology, Department of Preventive Medicine;
and 3Department of Medicine and Robert H. Lurie
Comprehensive Cancer Center, The Feinberg School of
Medicine, Northwestern University; and 4Department of
Medicine, Evanston Northwestern Healthcare
Background: Scleroderma (SSc) is a complex, multigenic, fi-
brotic disease. Transforming Growth Factor- (TGF-) is
thought to activate tissue fibroblasts causing fibrosis. The
aim of this study was to identify the associations between
genetic polymorphisms of the TGF- signaling pathway and
SSc.
Objective: We investigated the role of two common and
functionally relevant variants of the TGFB1 and TGFBR1
genes, in a clinically well-characterized cohort of SSc patients
and healthy controls. We tested the hypothesis that the hy-
pomorphic TGFBR1*6A allele is associated with a decreased
risk of developing SSc and that the TGFB1 T29C single nu-
cleotide polymorphism (SNP) that results in higher circulat-
ing levels of TGF- is associated with an increased risk of
developing progressive SSc.
Method: DNA from 80 consecutive patients with SSc who
fulfilled ACR criteria for diagnosis and 160 healthy controls
was genotyped. A case-control analysis was performed us-
ing conditional logistic regression to estimate age-, gender-,
race-, and smoking status-adjusted relative risk.
Results: A 6A/6A or 9A/6A genotype was associated with
an adjusted odds ratio for developing SSc of 0.651 (95% CI
0.270, 1.570). A CC/TC genotype was associated with an ad-
justed odds ratio of 0.624 (95% CI 0.323, 1.204).
Conclusion: Preliminary results suggest a trend toward an
association for lower risk of SSc with the TGFBR1 6A/6A or
6A/9A genotype, but the result is not statistically significant
(p0.339). Unexpectedly, the CC/TC genotype for the
TGFB1 ligand resulted in a decreased risk for SSc, though
the result was not statistically significant (p0.160).
P-20: Genetic Linkage Localizes the Adolescent
Idiopathic Scoliosis and Pectus Excavatum Gene to
Chromosome 18q
Christina A. Gurnett (presenting author),1,2,3 Farhang
Alaee,1 Anne Bowcock,4 Lisa Bauman,1 Lawrence G.
Lenke,1,6 Keith H. Bridwell,1,6 Timothy Kuklo,1,6 Scott J.
Luhmann,1,6 and Matthew B. Dobbs1,6
Departments of 1Orthopedic Surgery, 2Neurology, 3Pediatrics,
4Genetics, and 5Psychiatry, Washington University School of
Medicine; and 6Washington University School of Medicine and
St. Louis Shriners Hospital for Children
Background: Adolescent idiopathic scoliosis (AIS) and pectus
excavatum (PE) are common musculoskeletal conditions
known to have a genetic component, though few causative
genes have been identified.
Objective: To map the disease-causing locus in a large Cau-
casian family in which AIS and PE co-segregate.
Method: Clinical examinations were performed on the
proband, who underwent posterior spinal fusion, and 12 ad-
ditional affected family members. To map the gene causing
AIS and PE, a genome-wide linkage analysis was performed
with the Affymetrix Mapping 10K array on 13 affected and
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10 unaffected family members. Candidate genes were se-
quenced.
Results: AIS was present in 13 female family members and
PE was present in 3 males and 1 female. Genome-wide link-
age analysis resulted in a linkage peak on chromosome 18q
with a maximum parametric multipoint logarithm of the
odds (LOD) score of 3.86. Recombinants delineated the
critical genetic region to an interval of 6.4 cM region 
[corresponding to 7.06 Mb region (hg18: chr18:26342508–
34395660)]. The chromosome 18q linkage region contains
more than 30 genes. Resequencing of the coding regions of
21 candidate genes in the region did not reveal any causative
mutation.
Conclusion: Linkage analysis of this large family suggests
that an AIS and PE susceptibility gene resides on chromo-
some 18q. PE is common in families with AIS, and consid-
eration of family members with PE as affected may increase
the power of AIS genetic linkage studies.
P-21: Doublecortin Regulates Dendritogenesis
Through Interaction With Kinesin1a
Christopher A. Walsh1 and Judy Liu (presenting author)2
1Division of Genetics, the Children’s Hospital, Boston; and
2Department of Neurology, Beth Israel Deaconess 
Medical Center
Background: Mental retardation is a disorder that has a
greater prevalence in males compared to females. How mu-
tations in X-linked genes result in mental retardation is not
known. Work in animal models has revealed a role for dou-
blecortin, a gene that causes X-linked mental retardation and
epilepsy, in neuronal development.
Objective: To understand the cell biology of doublecortin
family proteins with respect to disease pathogenesis.
Method: We used dissociated hippocampal cultures from
Dcx/Dclk mutant embryos to characterize the different
stages of neuronal development with immunocytochemistry
and confocal imaging. We have used protein chemistry
methods to demonstrate an interaction with kinesin1a and
RNAi of kinesin 1a to phenocopy Dcx/Dclk effects.
Results: Characterization of Dcx-/y;Dclk-/- neurons in dis-
sociated cultures demonstrates a novel defect of dendrito-
genesis. There is a delay in the formation of the primary den-
drite. Likewise, the Golgi, which is associated with dendritic
morphology, does not track up the dendrite in the mutant
neurons. We show an interaction of Dcx with kinesin1a and
RNAi of kinesin1a phenocopies Dcx/Dclk knockdown with
respect to the dendritic and Golgi morphology.
Conclusion: These results point to a novel role of dou-
blecortin, a cytoskeletal protein, in the regulation of the Golgi
secretory apparatus during neuronal development, leading
to abnormal dendrites in the absence of functional Dcx/Dclk.
The effects of Dcx are likely mediated through its interaction
with the motor protein, kinesin 1a. Dendritic abnormalities
are associated with mental retardation and these may be the
basis of cognitive dysfunction in DCX patients, as well.
P-22: The Anti-Apoptotic Kinase Akt2 Is a Critical
Mediator of Glut1 Sensitive Neuronal Apoptosis
Penny J. Jensen, Laura B. Gunter, and Mary O.
Carayannopoulos (presenting author)
Department of Pediatrics, Washington University 
School of Medicine
Background: Glucose is the primary energy substrate for eu-
karyotic cells and the sole substrate for the brain. There is
increasing evidence that glucose serves an additional role in
the regulation of cellular functions including viability. Stud-
ies from our laboratory established zebrafish as a tractable
system for defining the cellular and molecular mechanisms
affected by impaired glucose metabolism. Inhibiting the ex-
pression of the ubiquitously expressed glucose transporter,
Glut1, results in severe embryonic neurodegeneration
caused by increased neuronal apoptosis.
Objective: The objective of this study was to define down-
stream components of the observed Glut1 sensitive apoptotic
pathway. Specifically, we aim to define the role of Akt2 as a
possible mediator.
Method: The method of targeted knockdown of Akt2 was
employed utilizing specialized anti-sense oligonucleotides,
morpholinos.
Results: Results reveal that impaired expression of Akt2
causes a syndrome similar to that observed by abrogation of
Glut1. Akt2 morphants exhibit increased neuronal apopto-
sis, impaired glucose uptake, and embryonic death by 72
hours-post-fertilization. Inhibiting the expression of the anti-
apoptotic protein, Bad, resulted in the inhibition of apopto-
sis and rescue of the Akt2 morphant embryos. Intriguingly,
we discovered that the Akt2 morphant embryos could also
be rescued by over-expression of Glut1.
Conclusion: The conclusions from this study are that Akt2
is integrally involved in the Glut1 sensitive apoptotic path-
way described previously. We hypothesize that Akt2 is af-
fecting glucose metabolism by decreasing expression of
Glut1 resulting in decreased glucose availability, which in
turn affects Akt2, whose activity is known to be dependent
on available glucose, culminating in the observed neurode-
generative phenotype.
P-23: Uncontrolled Asthma During Pregnancy 
Is Associated With an Exaggerated Th1:Th2
Cytokine Phenotype
James Temprano (presenting author),1 David M.
Mannino,2 Beth A. Garvy,3
1Division of Allergy and Immunology, Department of Internal
Medicine; 2College of Public Health; and 3Department of
Microbiology, Immunology, and Molecular Genetics, University
of Kentucky
Background: Asthma is a chronic inflammatory disorder of
the lower airways that is associated with a Type-2 helper T-
cell (Th2) cytokine environment. Uncontrolled asthma dur-
ing pregnancy has several adverse effects on the mother and
fetus. Identification of women who will experience uncon-
trolled asthma in pregnancy is difficult, but characterizing
the altered cytokine environment of pregnancy may help
identify those at risk.
Objective: To determine if an exaggerated Th2 cytokine en-
vironment characteristic of pregnancy will be associated
with uncontrolled asthma in pregnancy.
Method: Sixteen subjects (11 controls, 5 asthmatics) fol-
lowed during the 2nd and 3rd trimesters of pregnancy, com-
pleted Asthma Control TestsTM, spirometry, exhaled nitric
oxide, and blood draws at study visits. Peripheral blood
mononuclear cells were stimulated with phytohemagglu-
tinin and cell culture supernatants were assayed for cyto-
kines using a Luminex100 analyzer. Descriptive statistics and
t-tests were performed.
Results: Uncontrolled asthma was associated with a more
pronounced Th1 phenotype compared to controlled asthma
as assessed by the average IFN-:IL-4 ratio of each group
(45.84 vs. 9.49, respectively; p0.03). Similar trends were
found for other Th1:Th2 cytokine ratios, such as IFN-:IL-5
(1092.47 vs. 267.04, p0.15) and IFN-:IL-13 (11.69 vs. 2.27,
p0.11). Compared to healthy controls, uncontrolled asth-
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matics also demonstrated lower IFN-:IL-10 ratios (1.30 vs.
0.72, p0.03).
Conclusion: Uncontrolled asthma was associated with a
more pronounced Th1, and not Th2, cytokine environment
compared to controlled asthma. Further studies using these
cytokine ratios earlier in pregnancy to predict which asth-
matics will worsen should be performed.
P-24: The Cell Surface Phenotype of Uterine
Natural Killer Cells: Markers of uNK Activation
Thomas V. Mallidi,1 Suzanne R. Schloemann,1,2 and Joan
K. Riley (presenting author)1
Departments of 1Obstetrics and Gynecology, and 2Pathology
and Immunology, Washington University School of Medicine
Background: Recently a subset of natural killer (NK) cells 
was identified based on the cell surface phenotype
B220NK1.1CD11cCD11bCD27. This NK cell popu-
lation produces greater amounts of IFN- than conventional
NK cells. Phenotypically, these cells resemble human uter-
ine natural killer (uNK) cells; however, the physiologic role
of this murine cell population is unknown.
Objective: Determine whether murine uNK cells belong 
to the B220NK1.1CD11cCD11bCD27 subset of 
NK cells. Elucidate whether peripheral NK cells of the
B220NK1.1CD11cCD11bCD27 subset are specifi-
cally recruited to the uterus during gestation and/or
whether this cell surface phenotype is indicative of uNK cell
activation status.
Method: Uteri were isolated from virgin mice or pregnant
mice at E6.5–10.5. A single cell suspension was generated.
The cells were stained with specific antibodies and analyzed
by flow cytometry.
Results: The vast majority of uNK cells at E10.5 were
B220NK1.1CD11cCD11bCD27. uNK cells from vir-
gin mice expressed low levels of B220. However, B220 pro-
tein expression increased on a subset of uNK cells from E8.5
through E10.5. This is the time frame in which uNK cells be-
come activated. Moreover, the B220hi population of uNK
cells expressed activation markers, including ICOS, whereas
uNK cells derived from virgin mice did not.
Conclusion: uNK cells at E10.5 are B220NK1.1CD11c
CD11bCD27 similar to the recently characterized pe-
ripheral NK cell population. We speculate that uNK cell ac-
tivation is reflected by increased B220 expression. Thus we
believe B220hiNK1.1CD11cCD11bCD27 cells are ac-
tivated uNK cells. Studies are currently underway to deter-
mine whether B220 NK cells are preferentially recruited to
the uterus during pregnancy.
P-25: Nitric Oxide and Vascular Endothelial
Growth Factor During Pregnancy in Sickle 
Cell Disease
Julia E. Brittain (presenting author),1,2 John M. Thorp,1
and Eugene P. Orringer3
Departments of 1Obstetrics and Gynecology, 2Biochemistry and
Biophysics, and 3Medicine, University of North Carolina at
Chapel Hill
Background: Women with sickle cell disease (SCD) are more
likely to deliver small for gestational age (SGA) infants than
women without the disorder. Poor placental perfusion and
small infant size have long been attributed to sickle ery-
throcytes. However, patients with SCD are deficient in the
vasodilator nitric oxide, NO, which could compromise va-
sodilation in the placental vascular bed. A potent inducer of
NO release is VEGF. Pregnant women with SCD have high
plasma levels of a VEGF antagonist, sFLT-1, which has been
implicated in SGA infants. Although there may be a rela-
tionship between NO, VEGF, and sFLT-1 in SCD, no study
has sought to explore this association or its impact on SGA
infant status.
Objective: To interrogate levels of NO, free VEGF, and
sFLT-1 during pregnancy in SCD and to explore the rela-
tionship between NO, sFLT-1, and SGA infant status.
Method: We performed an analysis of previously col-
lected plasma/serum samples obtained through the Preg-
nancy, Infection, and Nutrition study cohort. Levels of 
free VEGF and sFLT-1 were quantified by ELISA. NO was
quantified via its metabolite NOx using a modified Griess
method.
Results: Free VEGF and NO were significantly lower in
pregnant women with SCD than in matched pregnant con-
trols. We also found a significant association between NOx
and sFLT-1 levels. Pregnant women with SCD who deliv-
ered an SGA infant also had significantly lower levels of NOx
than those women who did not.
Conclusion: These results suggest that impaired release NO
may play a role in SGA infant status in SCD pregnancies.
P-26: Human Cumulus Cells in Culture: Tools To
Evaluate Oocyte Quality?
Jessica K. Wickenheisser (presenting author),1 Richard S.
Legro,2 William C. Dodson,2 Jan M. McAllister1,2
Departments of 1Cellular and Molecular Physiology, and
2Obstetrics and Gynecology, Milton S. Hershey Medical Center,
College of Medicine, Pennsylvania State University
Background and Objective: Within ovarian follicles, cumulus
granulosa cells surround the oocyte and play crucial roles
during oocyte growth, development, and maturation. Cu-
mulus cells, therefore, may serve as indicators of oocyte
quality during assisted reproductive technology (ART).
However, little is known about human cumulus cell func-
tion or regulation. Here, we examine the production of es-
trogen and progestins by cumulus cells in culture, their re-
sponse to pituitary gonadotropins, luteinizing hormone
(LH) and follicle-stimulating hormone (FSH), and their pro-
tein profile(s).
Method: Cultured cumulus cells were isolated from
oocytes collected from women undergoing ART. Proges-
terone and estradiol were measured by EIA following treat-
ment with forskolin, FSH, or human chorionic gonado-
tropin (hCG). Aromatase activity, necessary for estrogen
biosynthesis, was determined by tritiated water assay.
mRNA accumulation was quantitated by real-time PCR.
Protein profiles of cumulus cell extracts were examined by
iTRAQ analysis.
Results: Estradiol biosynthesis, P450 aromatase activity,
and associated CYP19 mRNA accumulation were elevated
by forskolin, hCG, or FSH treatment. P450 cholesterol side-
chain cleavage (CYP11A1) mRNA and progesterone biosyn-
thesis were similarly induced by hCG or FSH. Proteomic
analyses revealed a subset of proteins with altered abun-
dance (increased or decreased) in hCG-treated cells, as com-
pared to nonstimulated cells.
Conclusion: Cultured cumulus cells are steroidogenic cells
that respond to gonadotropins with increases in progester-
one and estradiol biosynthesis and associated mRNA ex-
pression. Further evaluation of cumulus cell steroidogenesis
and protein profiles from individual oocytes may reveal cu-
mulus-specific function(s) during follicular development
and identify markers of oocyte competence to improve out-




by Inhibition of Foxo3a Activation
Peixin Yang (presenting author),1 Zhiyong Zhao,1,2
E. Albert Reece,1,2 and Richard L. Eckert2
Departments of 1Obstetrics, Gynecology, and Reproductive
Sciences, and 2Biochemistry and Molecular Biology, University
of Maryland School of Medicine
Background: Maternal hyperglycemia increases risks of con-
genital malformations. Hyperglycemia-induced oxidative
stress is responsible for this teratogenic effect. Hyperglycemia
triggers activation of Foxo3a (Forkhead transcription factor
3a), manifested in the reduction of phosphorylated Foxo3a
(pFoxo3a) at threonine 32, which leads to Foxo3a nuclear
translocation. Foxo3a mediates oxidative stress signaling and
may be involved in hyperglycemia-induced malformations.
EGCG, a natural antioxidant, is a purified green tea compound
that inhibits oxidative stress signaling. Thus, we propose that
EGCG prevents hyperglycemia-induced malformation via in-
hibition of oxidative stress signaling.
Objective: In this study, we examined the effect of EGCG on
hyperglycemia-induced malformation and Foxo3a activation.
Method: Embryonic day 9 rat conceptuses were cultured un-
der euglycemic (150 mg/dl) and hyperglycemic (300 mg/dl
glucose) conditions with or without 1 or 10 M EGCG. After
48 h, embryos were dissected from yolk sacs and morpho-
logically examined for malformations. Levels of pFoxo3a and
pAkt, a kinase that specifically inhibits Foxo3a activation,
were determined in embryonic lysates by Western blotting.
Results: At concentrations of 1 M or 10 M, EGCG had
no teratogenic effect on embryonic development. Both 1 M
and 10 M EGCG completely prevented hyperglycemia-in-
duced embryonic malformations. While hyperglycemia in-
activated Akt by reducing pAkt levels, EGCG reversed the
inhibitory effect of hyperglycemia on Akt activation. EGCG
prevented hyperglycemia-reduced pFoxo3a levels and thus
abolished hyperglycemia-induced Foxo3a activation.
Conclusion: EGCG prevents hyperglycemia-induced mal-
formation in vitro through inhibition of Foxo3a activation.
This may have been mediated via the activation of Akt. These
findings offer the potential for a possible pharmacological
prophylaxis.
P-28: Development of a Novel Three-Dimensional
Ovarian Organ Culture To Study Surface Repair as
a Mechanism for Ovarian Cancer Formation
Joanna Burdette (presenting author), Kari Inoue, and
David Davis
Department of Medicinal Chemistry and Pharmacognosy,
University of Illinois at Chicago
Background: The fewer times a woman ovulates, the lower
her risk for developing ovarian cancer. Ovarian cancer is dif-
ficult to study due to the lack of models for identifying
changes in the ovarian surface epithelium (OSE), the cells re-
sponsible for 90% of ovarian cancers.
Objective: We sought to establish that repeated tear and re-
pair of the OSE from ovulation increases the risk of ovarian
cancer due to enhanced proliferation and migration of the OSE.
Method: We developed a novel three-dimensional ovarian
organ culture using artificially wounded ovaries embedded
into alginate gels.
Results: Using an ovarian organ culture, OSE repopulated
the outer surface of the wounded tissue in a time-dependent
manner. The cells that encapsulated the wounded surface
maintained characteristics of normal, healthy OSE cells such
as expression of cytokeratin 8, N-cadherin, vimentin, and an
absence of E-cadherin. Growth of ovarian organ cultures in
medium supplemented with bovine serum albumin in-
creased the proliferation of OSE based on bromodeoxyuri-
dine incorporation while medium supplemented with fetal
bovine serum enhanced OSE cell migration. The fastest pro-
liferation rates were measured after wounding on day 2 and
slowed as the surface became more highly encapsulated.
Conclusion: Ovarian surface repair can now be studied in
vitro using an organ culture model and reveals that the
wounding process induces proliferation and migration of the
OSE. Because a hallmark of cancer is the process of uncon-
trolled proliferation and migration of cells, our studies con-
nect the process of wound repair as it relates to ovulation
and cancer formation.
P-29: Parity Is Associated With Altered Collagen
Subtypes and Inferior Biomechanical Properties in
the Primate Vagina
Steven Abramowitch (presenting author),1,2 Andrew
Feola,1 Keisha Jones,2 Zegbeh Jallah,1 and Pamela Moalli2
1Department of Bioengineering, Musculoskeletal Research
Center; and 2Magee Women’s Research Institute, Department
of Obstetrics and Gynecology and Reproductive Sciences at
Magee Women’s Hospital, University of Pittsburgh
Background: Vaginal injury at the time of delivery is consid-
ered one of the greatest risk factors for developing a pelvic
floor disorder later in life.
Objective: The objective of this study was to quantify the
extent of injury or incomplete recovery following vaginal de-
livery by comparing the collagen ratios and uniaxial me-
chanical properties of the vaginal wall in parous and nulli-
parous nonhuman Rhesus macaques.
Method: The vaginas of six parous (median vaginal parity
of 7) at least 1 year from the most recent delivery and three
nulliparous primates were utilized. Fibrillar collagens I, III,
and V present in the subepithelium of the midvagina were
assessed via quantitative fluorescence microscopy (N3 in
both groups). To measure the mechanical properties of the
vagina, a uniaxial tensile test was performed on all speci-
mens. Biochemical and biomechanical data were compared
using a Mann-Whitney test with significance set at p0.05.
Results: Parity was associated with a decrease in the ratio
of collagen I/IIIV in the subepithelium (0.310.04 vs.
0.140.06, p0.05), primarily due to an increase in collagen
III. Correspondingly, the parous group demonstrated a sig-
nificantly lower tensile strength and strain-energy density,
which both measured 2.5 times less that of the nulliparous
group (p 0.05).
Conclusion: Parity is associated with altered collagen sub-
types and inferior biomechanical properties resulting in a de-
crease in the ratio of collagen I/IIIV as well as a decrease
in strength and toughness. These changes may contribute to
the progression of pelvic organ prolapse over time.
P-30: Effects of Estrogen on the 
Biophysical Properties of Hippocampal CA1
Pyramidal Neurons
Wendy W. Wu (presenting author),1 John P. Adelman,2
and James Maylie1
1Department of Obstetrics and Gynecology, and 2Vollum
Institute, Oregon Health and Science University
Background: For female ovariectomized animals, the longer the
time interval between surgery and the initiation of estrogen re-
placement therapy, the less responsive the neural tissue be-
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comes to exogenous estrogen treatment. Estrogen regulates
gene expression and neuronal activity in many central neurons.
Objective: To test whether or not the expression profiles of
ion channels and receptors that directly bind estrogen are
gradually altered following estrogen withdrawal.
Method: Whole-cell current clamp recordings were used to
assess the intrinsic membrane excitability of hippocampal
CA1 pyramidal neurons from ovariectomized female rats
that were deprived of estrogen for either 7 days or 5 months
(short- or long-term estrogen deprivation).
Results: Bath application of estrogen significantly in-
creased the excitability of CA1 pyramidal neurons from only
short-term, but not long-term, estrogen-deprived rats. Long-
term estrogen deprivation significantly reduced the ex-
citability of CA1 pyramidal neurons.
Conclusion: Estrogen is important in maintaining the cel-
lular profile of ion channels and receptors that regulate the
excitability of CA1 pyramidal neurons. As the hippocampus
is crucial for learning and memory and CA1 pyramidal neu-
rons are its principle output neurons, these results may be
related to the intriguing clinical findings that estrogen re-
placement therapy impedes age-related cognitive decline in
women only when initiated near the time of menopause, but
not 10 or more years following menopause. Understanding
the actions of estrogen on CA1 pyramidal neurons and iden-
tifying its targets are pivotal steps toward evaluating current
strategies for estrogen replacement therapy and will lead to
the design of gender-specific therapeutic interventions to
treat cognitive deficits.
P-31: 2-Methoxyestradiol Induces Apoptosis of
Pulmonary Microvascular Endothelial Cells: A
Potential Therapy for Pulmonary Hypertension
Lori Sweeney
Divisions of Endocrinology and Metabolism, Virginia
Commonwealth University Health System
Background: Primary pulmonary hypertension (PH) is a rel-
atively rare but lethal disorder characterized by poor median
survival rates. Current research suggests the culprit lesion
in PH comprises highly proliferative vascular endothelial
cells that are resistant to apoptosis. A particularly intriguing
aspect of this research is the potential for estrogen metabo-
lites with potent growth inhibitory effects to influence this
process. 2-Methoxyestradiol (2-ME) is a potent anti-estrogen
metabolite that inhibits angiogenesis and promotes apopto-
sis in multiple cell lines. It is being administered in several
phase-II clinical trials in disease states and may represent a
potential therapy in PH.
Objective: To evaluate the effects of 2-ME on human pul-
monary vascular endothelial cell apoptosis and explore po-
tential mechanisms involved in 2-ME-induced apoptosis.
Method: HMPVC were purchased and maintained in sup-
plemented media. 2-ME was added, and cellular prolifera-
tion was assessed by MTT colorimetric assay. In additional
experiments 2-ME-induced cellular apoptosis was assessed
by flow cytometry. Lastly, RNA was extracted from 2-ME-
treated cells, and QPRC for UPR targets was performed.
Conclusion: Treatment of human pulmonary microvascu-
lar endothelial cells with 5uM 2-ME at 48 h resulted in de-
creased cellular proliferation as compared to controls. 2-ME-
induced reduction in cell proliferations was not affected by
co-incubation with estradiol or SHBG. 2-ME-induced apop-
tosis of HMPVC in a dose-dependent manner. This treatment
was associated with increased expression of key targets in
the unfolded protein response. These results suggest that 2-
ME-induced apoptosis may involve the endoplasmic reticu-
lum stress response.
P-32: Severe Pulmonary Hypertension Is
Associated With an Increased Plasma Ratio of
Estrogenic to Antiestrogenic Metabolites
Lori Sweeney
Divisions of Endocrinology and Cardiology, Virginia
Commonwealth University Health System
Background: Severe pulmonary hypertension (PH) is a lethal
disorder characterized by marked angiogenesis and endo-
thelial cell proliferation in the microcirculation of the lung.
PH affects women disproportionately. The female-male ra-
tio is 3:1, and the gender differences are observed in the id-
iopathic as well as secondary forms of the disease. These sex-
based differences are particularly intriguing given the
potential for sex steroids to modulate key pathogenic pro-
cesses in severe PH. The major estrogen produced in the
ovaries is 17-B estradiol (E2). E2 is a potent inducer of en-
dothelial cell proliferation in the lung. E2 can be further
detoxified to 2-ME. This metabolite is distinctly anti-estro-
genic and induces apoptosis in several cell lines. Inter-indi-
vidual differences exist in key enzymes required for estro-
gen detoxification. Such differences may predispose to the
development of diseases characterized by angiogenesis such
as severe PH.
Objective: To assess for an estrogen metabolite profile that
would favor angiogenesis in patients with established severe
PH.
Method: Plasma was collected from patients referred for
evaluation of PH in our multidisciplinary PH clinic. Quan-
tification of circulating endogenous estrogens was per-
formed via liquid chromatography-tandem mass spectrom-
etry. The ratio of E2 to the anti-estrogen metabolite 2-ME was
compared between patients meeting criteria for severe PH
and controls.
Results: The ratio of E2 to 2-ME was significantly higher
in patients with severe PH as compared to controls. Further
study is warranted to evaluate these preliminary associations
between estrogen tone and severe PH.
P-33: Cell-Type-Specific Regulation of
Transcription by Estrogen
Susan A. Krum (presenting author)1 and Myles Brown2
1Department of Orthopedic Surgery, University of California,
Los Angeles; and 2Medical Oncology, Dana-Farber Cancer
Institute
Background: Estrogen is an important regulator of develop-
ment and plays a role in the bone, among other tissues. Many
of the genes regulated by estrogen in the bone remain un-
known, and the mechanism by which estrogen exerts tissue-
specific effects remains to be explained.
Objective: To identify osteoblast- and breast-specific genes
regulated by estrogen and to understand the mechanism of
tissue specificity.
Method: We have compared the global gene expression
profile of the MCF7 breast cancer cell line with that of the
osteoblast-like cell line U2OS-ERa by expression microar-
rays, and we compared the ER alpha binding sites in the two
cell types by performing chromatin immunoprecipitation
(ChIP) on genomic tiling arrays (ChIP-on-chip).
Results: We find that fewer than 10% of the estrogen-reg-
ulated genes are common to both cell types. We have vali-
dated many of these genes in primary calvarial osteoblasts.
ERalpha binding in U20S-ERa cells best correlates with genes
up-regulated in U20S-ERa cells, and ERalpha is recruited to
multiple enhancers near genes induced by estrogen. Inter-
estingly, while the forkhead factor FoxA1 plays a critical role
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in defining the ERa binding sites in MCF7 cells, it is not ex-
pressed in U2OS-ERa cells, and forkhead motifs are not en-
riched in the ERalpha binding sites in these cells. Finally, the
ERalpha binding sites are correlated with cell-type-specific
epigenetic histone modifications.
Conclusion: These results support a model for the cell-type-
specific action of estrogen being driven primarily through
specific ERalpha occupancy of epigenetically marked cis-reg-
ulatory regions of target genes.
P-34: The Role of ABC Transporter in Export of
Sphingosine 1-Phosphate From Breast Cancer Cell
Kazuaki Takabe (presenting author),1,2 Paulami Mitra,2
and Sarah Spiegel2
1Division of Surgical Oncology, Department of Surgery, and
2Department of Biochemistry and Molecular Biology, Virginia
Commonwealth University School of Medicine
Background: Sphingosine 1-phosphate (S1P) is an active lipid
mediator, which plays critical roles in cancer progression.
S1P is produced by only two specific isoenzymes, sphingo-
sine kinase 1 (SphK1) and 2 (SphK2). SphK1 is over-ex-
pressed in breast cancer. S1P binds to its specific receptors
on the cell surface and exerts its biological effects. However,
it is not known how intracellularly produced S1P is exported
out of these cells.
Objective: To investigate whether ABC transporter plays a
role in S1P export of breast cancer, and to examine whether
SphK1 or SphK2 is responsible for the export of S1P.
Method: MCF-7 breast cancer cells were used as a model.
SphK1 and SphK2 were over-expressed by transfection of re-
spective plasmid, and knocked down using specific siRNAs.
S1P was measured using 3H labeled sphingosine, and mass
spectrometer.
Results: Over-expression of SphK1, but not SphK2, in-
creased S1P export, although both similarly increased intra-
cellular levels of S1P. Conversely, down regulation of SphK1,
but not SphK2, decreased export of S1P. Estradiol phospho-
rylated SphK1 immediately after stimulation that resulted in
S1P export, which was inhibited by an inhibitor of ABCC1
and ABCG2, but not ABCB1.
Conclusion: This is the first demonstration in which the
multidrug resistant transporters, ABCC1 and ABCG2, are in-
volved in estradiol-induced export of S1P. Further, SphK1,
but not SphK2, is responsible for production of the S1P ex-
ported from breast cancer cells. These findings have impor-
tant clinical implications as exported S1P may play an im-
portant role in breast tumor progression.
P-35: Monoclonal Antibody Against Transforming
Growth Factor  Ligands Inhibits Bone Metastasis
in a Preclinical Model
Swati Biswas (presenting author),1,2 Clayton R Wilburn,2
Steve A. Munoz,2 Julie A. Sterling,1,2 Scott
Lonning,3Gregory R. Mundy1,2
1Department of Cancer Biology and 2Vanderbilt Center for
Bone Biology, Vanderbilt University; and 3Pharmacology and
Toxicology, Genzyme Corporation
Background: Transforming growth factor  (TGF) promotes
breast cancer bone metastasis, by modulating both cancer
cells and the bone microenvironment. Inhibiting TGF sig-
naling by small molecule kinase inhibitors reduces tumor
burden and bone lesions in preclinical bone metastasis mod-
els. However, nonspecific side effects of these compounds
are not uncommon.
Objective: In this study, we tested the hypothesis that sys-
temic administration of a pan-TGF antibody, 1D11(Gen-
zyme corporation), might reduce tumor burden in bone.
Method: An experimental bone metastasis model was
used for this study, where MDA-MB-231 human breast can-
cer cells were injected in 4–5-week-old female nude mice
via the left cardiac ventricle. Tumor-bearing mice were
treated with either 1D11 or control antibody (13C4) i.p.
three times every week for 2 weeks. Treatment was initi-
ated 2 weeks after tumor inoculation. Efficacy of 1D11 on
metastatic progression of breast cancer cells in bone was
tested using faxitron analysis of bone lesions, microCT anal-
ysis on bone volume, and histomorphometry to examine
tumor burden in bone.
Results: Treatment with 1D11(10mg/Kg, three times a
week for 2 weeks) reduced the number of bone lesions
(Control: 7.4, Treated: 2.3, P.005), and area of bone lesions
(control: 7535.5 cm2, treated: 865.5 cm2, P.001) and in-
creased tibial bone volume (Control: 0.093, Treatment:
0.198, P.01).
Conclusion: Anti-TGF antibody, thus, effectively reduces
metastatic bone lesions in human breast cancer metastasis to
bone. We are investigating the molecular mechanisms by
which this anti-TGF antibody 1D11 reduces bone metasta-
sis.
P-36: Breast Adipose Participates To Bioactivate
Vitamin D3 and Inhibit Breast Cancer
Glendon M. Zinser (presenting author), Stephen Ching,
and Susan E. Waltz
Department of Surgery, University of Cincinnati
Background: Vitamin D3 is a nutritionally modulated hor-
mone that participates as a negative growth regulator of
mammary gland development and transformation. How-
ever, the mechanism behind tissue-specific vitamin D3 syn-
thesis, metabolism, and signaling to maintain glandular ho-
meostasis and inhibit the onset of mammary transformation
remains unknown.
Objective: Our objective is to test the concept that vitamin
D3 signaling in mammary adipose tissue contributes to the
negative growth regulation of mammary epithelial cells. Our
hypothesis is that the mammary adipose tissue bioactivates
dietary 25-hydroxyvitamin D3 [25(OH)D3] to the active me-
tabolite, 1a,25-dihydroxyvitamin D3 [1,25(OH)2D3], and in-
duces adipocyte vitamin D3 receptor (VDR) signaling along
with paracrine secretion of 1,25(OH)2D3 to surrounding
mammary epithelial cells to regulate growth of normal and
transformed breast epithelial cells.
Method: We utilized mammary glands from VDR knock-
out (KO) and wild type (WT) mice for various procedures
including ex vivo co-cultures with mammary epithelium and
adipocytes, gene and protein expression assays, immuno-
histochemistry, and whole mounts.
Results: Breast adipocytes express the essential signal-
ing components of the vitamin D3 endocrine system and
have the ability to bioactivate 25(OH)D3 to 1,25(OH)2D3
inducing mammary-specific vitamin D3-responsive gene
expression, suggesting that mammary adipose tissue
participates in maintaining localized vitamin D3 homeo-
stasis and contributes to regulate the growth of mammary
epithelial cells in response to various hormonal stimula-
tions.
Conclusion: Our work suggests that breast adipose tissue
serves as a vital endocrine mediator of vitamin D3 signaling
and offers a possible mechanism by which elevated
25(OH)D3 serum concentrations reduce the susceptibility to
breast cancer.
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P-37: Potential Roles for CCL2 and CXCL1
Inflammatory Chemokine Signaling in Fibroblast:
Mammary Carcinoma Cell Interactions
Anna Chytil,1 Bojana Jovanovic,1 and Nikki Cheng
(presenting author)2
1Department of Cancer Biology, Vanderbilt University; and
2Department of Pathology and Laboratory Medicine, Kansas
University Medical Center
Background: While diagnosis and treatment for breast cancer
has improved over decades, metastatic spread remains a
poorly understood disease with few treatment options. Stud-
ies have shown that stromal fibroblasts influence breast can-
cer cell growth and invasiveness through secretion of solu-
ble factors. Data from our laboratory suggest that secretion
of inflammatory chemokines from fibroblasts, in particular
CCL2 and CXCL1, may significantly affect breast cancer pro-
gression. While studies have shown that chemokines regu-
late immune cell recruitment during inflammation, we hy-
pothesize that chemokine signaling also regulates fibroblast
interactions with carcinoma cells to mediate breast carci-
noma growth and metastatic spread.
Objective: To analyze the functional contributions of CCL2
and CXCL1 signaling in fibroblast: epithelial interactions
during breast cancer progression.
Method: Cultured mouse and human fibroblasts were sub-
ject to cDNA and protein array profiling and RT-PCR and
ELISA analyses. Fibroblasts were co-cultured with carcinoma
cells and analyzed for migration by transwell assays in the
presence of neutralizing antibodies to CCL2 and CXCL1.
Mouse fibroblasts were co-implanted with carcinoma cells
into nude mice, treated with neutralizing antibodies to CCL2
and analyzed by histological and biochemical analyses.
Results: Expression profiling analyses show high-level ex-
pression of CCL2 and CXCL1 in mouse and human fibro-
blasts. Fibroblast-conditioned medium enhanced the migra-
tion and invasion of carcinoma cells, which was abrogated
in the presence of CCL2 and CXCL1 neutralization. Tumor-
bearing mice treated with CCL2 inhibitors showed signifi-
cant decreased tumor growth and metastasis.
Conclusion: CCL2 and CXCL1 regulate fibroblast interac-
tions with mammary carcinoma cells during tumor growth
and metastasis.
P-38: Bombesin and Epidermal Growth Factor
Increase Breast Cancer Cell Migration and
Interleukin-8 Expression
Celia Chao (presenting author), Courtney M. Townsend,
Jr., and Mark R. Hellmich
Department of Surgery, University of Texas Medical Branch
Background: Over-expression of members of the epidermal
growth factor (EGF) family of receptor tyrosine kinases corre-
lates with poor prognosis in breast cancer. In vivo and in vitro
models of breast cancer have shown that BBS (amphibian) or
gastrin-releasing peptide (GRP-mammalian) and their cognate
receptor, GRP receptor (GRPR), promote cancer growth.
Objective: The aim of this study is to demonstrate that BBS
and EGF cooperate to contribute to breast cancer progression.
Method: MDA-MB-231 breast cancer cells over-express
both EGFR and GRPR. Cellular proliferation after treatment
with BBS, EGF, or both was assessed in serum-starved cells
by Coulter counter. Migration was performed using Tran-
swell chambers. The migrated cells were fixed, stained, and
quantified. Northern blot and real-time PCR were used to
evaluate if proangiogenic factor interleukin-8 (IL-8) mRNA
increased with addition of EGF, BBS, or both. Western blot
for phosporylated ERK was used to assess activation of the
mitogen-activated protein kinase (MAPK) pathway.
Results: Stimulation with EGF and BBS increased cell mi-
gration, phosphorylated ERK, and synergistically upregu-
lated IL-8 mRNA, compared to no treatment, EGF, or BBS
alone. However, with regard to cellular proliferation, no dif-
ferences were found between cells treated with EGF, BBS, or
the combination.
Conclusion: GRPR and EGFR cooperate to regulate cell mi-
gration, IL-8 expression, and MAPK activation, but not cell
proliferation in MDA-MB-231 breast cancer cells. Identifying
pathways that lead to hyperactivation of EGFR signaling,
such as cooperative signaling by GRPR, is critical for im-
proving rational design of combination drug regimens for
breast cancer.
P-39: Cyclin D1 Can Act as a Positive or Negative
Effector in AIB1-Mediated Tumorigenesis
Maria I. Torres-Arzayus (presenting author),1,2 Jin Zhao,1
and Myles Brown1
1Division of Molecular and Cellular Oncology, Department of
Medical Oncology, Dana-Farber Cancer Institute; and
2International Center of Physics, National University of Colombia
Background: AIB1 is a member of the p160 family of estrogen
receptor (ER) transcriptional coactivators. We showed pre-
viously that over-expression of AIB1 in transgenic mice leads
to mammary hypertrophy, hyperplasia, and a high incidence
of multiple tumors involving mammary gland as well as pi-
tuitary, uterus, and lung. AIB1 over-expression resulted in
increased cyclin D1 mRNA and protein levels.
Objective: To determine whether cyclin D1 is an effector of
AIB1-induced oncogenesis.
Method: AIB1 transgenic mice were crossed with cyclin 
D1/ mice to generate double mutant mice. Microscopic
analyses of mammary gland development were performed
using H&E stained whole mounts and immunohistochemi-
cal analysis of ER, AIB1, and cyclin D1 expression. Rates of
tumor formation for various tumor types were determined.
Results: AIB1 over-expression did not rescue the cyclin 
D1/ mammary gland phenotype, namely failure to reach
the lobulo-alveolar phase of development during pregnancy
in order to enable lactation. More importantly, unlike the
AIB1 transgenic mice, double mutant mice did not develop
mammary gland, uterus, pituitary, or lung tumors. Surpris-
ingly, double mutants developed a high incidence of lym-
phomas. This tumor type was not observed in AIB1 trans-
genic mice or in cyclin D1/ mice.
Conclusion: (1) Cyclin D1 is required for the formation of
all tumor types observed in the AIB1 tumor model. There-
fore, cyclin D1 is a downstream effector of AIB1. (2) Abla-
tion of cyclin D1 in AIB1 transgenic mice leads to a high in-
cidence of lymphomas, indicating that in certain tissue types
cyclin D1 may act as a tumor suppressor.
P-40: Women Have Elevated Lipid Concentrations
8 Years After Preterm Births Not Complicated by
Preeclampsia or Growth Restriction
Janet M. Catov (presenting author),1,2 James M. Roberts,1,2,3
Kim S. Tyrrell,2 Gail Harger,2 and Roberta B. Ness1,2
Departments of 1Obstetrics, Gynecology, and Reproductive
Sciences, and 2Epidemiology; and 3Magee-Womens Research
Institute, University of Pittsburgh
Background: Women with preterm birth (PTB) are at in-
creased risk for cardiovascular disease (CVD), but mecha-
nisms are not understood.
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Objective: Women with spontaneous PTB have early ges-
tation dyslipidemia, and we studied lipid aberrations post
partum.
Method: Women who delivered preterm (34 weeks,
n41; 34–37 weeks, n18) were compared to 183 women
with term births (37 weeks). Women with preexisting
medical conditions, preeclampsia or growth restriction, were
excluded. Mean lipid concentrations at 8 years post partum
were compared.
Results: Women with a prior preterm (pPTB) v. term birth
had higher concentrations of total cholesterol, and women
with pPTB 34 weeks had the highest concentrations (34
weeks, 203.8.1; 34–37 weeks, 188.8; 37 weeks, 183.7;
p0.01). Results were similar for apolipoprotein-B (APOB)
and LDL. After adjustment for race, age, smoking, and body
mass index, total cholesterol among women with pPTB 34
weeks was on average 19.3 mg/dl higher (p0.01), LDL was
14.3 mg/dl higher (p0.01), and APOB was 10.9 mg/dl
(p0.01) higher compared to women with term births.
Women with pPTB were 3.0 (1.2, 7.8) times more likely to
have cholesterol 240 and 2.7 times (95% CI 1.0, 7.4) more
likely to have LDL 160 compared to women with term
births, after covariate adjustment. Triglyceride concentra-
tions tended to be higher in women with pPTB 34 weeks
(p0.09), but there were no differences in HDL.
Conclusion: Eight years post partum, women with a his-
tory of spontaneous pPTB had substantially elevated athero-
genic lipid concentrations. Dyslipidemia may be a mecha-
nism linking PTB to later CVD.
P-41: Identification of Critical Gel Properties for
Describing Delivery of Vaginal Gels
Sarah L. Kieweg
Department of Mechanical Engineering, School of Engineering,
and Department of Obstetrics and Gynecology, School of
Medicine, University of Kansas
Background: Vaginally delivered microbicide gels need to cover
and protect epithelial surfaces. Epithelial coverage is deter-
mined by a gel’s physical properties and response to tissue
squeezing forces. Our long-term goal is to optimize gel struc-
ture to yield ideal gel properties. However, first we need to
identify what gel properties are critical for describing how a gel
spreads due to squeezing. Previous studies indicate that visco-
metric power-law parameters (consistency and shear-thinning)
do not sufficiently describe all squeezing flow experiments.
Objective: To determine if independently measured power-
law parameters are sufficient to describe applied-rate
squeezing flow experiments of a hydroxyethylcellulose
(HEC) gel used in microbicide clinical trials as a “universal
placebo.” This study examines the effects of HEC concen-
tration, squeezing rate, and squeezing configuration (con-
stant-radius or constant-volume).
Method: We quantitatively evaluated the appropriateness
of power-law parameters in two ways. First, previous vis-
cometric measurements of power-law parameters were used
as input to a mathematical squeezing model. Theoretical re-
sults were compared to previous experimental squeezing
data using a goodness of fit measurement. Second, we fit the
power-law parameters of the theoretical model directly to
experimental squeezing data.
Results: For both rates and both HEC concentrations,
power-law parameters adequately described constant-radius
squeezing experiments, but not constant-volume squeezing
experiments.
Conclusion: This is a new study evaluating constant-volume
squeezing of HEC gels and has physiological relevance to vagi-
nal delivery of the universal placebo. These data suggest that
other properties, such as viscoelastic measurements, may be
needed to describe constant-volume squeezing flows. Further
studies will examine other concentrations, rates, and volumes.
P-42: Baseline Characteristics of the Participants of
a Randomized, Double-Blind, Placebo-Controlled
Trial of Atorvastatin for the Treatment of Women
With Polycystic Ovary Syndrome
Nazia Raja-Khan (presenting author)1 and Richard S. Legro2
1Division of Endocrinology and 2Department of Obstetrics and
Gynecology, Pennsylvania State University
Background: As LDL-cholesterol is the primary precursor for
sex steroid synthesis, dyslipidemia may play a central role in
the pathogenesis of polycystic ovary syndrome (PCOS). Many
women with PCOS have mild to moderate dyslipidemia, but
do not meet the current National Cholesterol Education Pro-
gram indications for statin therapy. The specific aim of this
project is to determine whether atorvastatin will improve the
cardiometabolic phenotype of women with PCOS.
Objective: To report the baseline characteristics and meta-
bolic profile of our study cohort.
Method: LDL-cholesterol was measured in 28 women with
PCOS, ages 18–40 years. Seventeen women with PCOS and
LDL-cholesterol 100 mg/dl were randomized to atorvas-
tatin 40 mg daily or placebo for 6 weeks. Our primary out-
come is change in brachial artery flow-mediated dilatation
(FMD), a noninvasive measure of endothelial function. Major
secondary outcomes include hormonal and metabolic profiles.
Results: LDL-cholesterol was 100 mg/dl in 20 of 28 (71%)
women with PCOS. The mean (SD) age of the randomized
subjects was 31.94.2 years, and the mean body mass index
was 38.312.2 kg/m2. The mean testosterone level was 74.9
44.8 mg/dl. The mean LDL-cholesterol level was 130.824.9
mg/dl. One woman had elevated fasting glucose 100 mg/dl,
and four women had elevated glucose 2 hours after a 75-gram
oral glucose load. The mean fasting glucose-insulin ratio was
7.24.2. The mean baseline FMD was 12.86.3%.
Conclusion: Many women with PCOS have elevated LDL-
cholesterol and may benefit from stain therapy.
P-43: Platelet Activation in Acute Ischemic Stroke:
Gender Differences and Subtypes of 
Ischemic Stroke
Anand Vaishnav (presenting author) and Suellen Ferraris2
1Department of Neurology and 2Division of Cardiothoracic
Surgery, Department of Surgery, University of Kentucky
Medical Center
Background: Platelets are activated in acute ischemic stroke
(AIS), and they secrete P-selectin, which potentiates vascu-
lar injury. Antiplatelet agents are recommended for sec-
ondary prevention of ischemic stroke. Thus, there are treat-
ment implications if one can objectively prove that platelet
activation differs in the subtypes of AIS. Postmenopausal
women have unique characteristics related to ischemic
stroke: increased incidence, higher morbidity and mortality,
and poor response to antiplatelet agent. Whether this find-
ing is related to hormonal differences or differences in in-
herent platelet function is not clear.
Objective: The purpose of this study is to measure the ex-
pression of P-selectin using flow cytometry in AIS patients
to determine whether activation differs between gender and
stroke subtypes.
Method: Whole blood samples were collected on AIS patients,
and flow cytometry was performed to measure activation of
platelets in men and women, and in two subtypes of AIS: large
vessel atherosclerosis (LVA) and lacunar (LAC) strokes.
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Results: Flow cytometry was performed on 40 patients. Of
the 40 patients, 26 (13 females) had lacunar strokes, while 14
(4 females) were strokes caused by LVA. In this small sample
study, there was no significant difference in the platelet acti-
vation between males and females. LVA strokes had a trend
toward higher platelet activation than LAC strokes (P.071).
Conclusion: Platelet activation differs in different subtypes
of AIS, though larger studies are needed to substantiate the
difference in platelet activation between subtypes of stroke.
No gender differences in platelet activation were noted,
though ongoing studies will confirm our results.
P-44: Familial and Gender Influences on
Adolescent Weight Status: A Latent Class Analysis
Jerica Berge (presenting author),1 Melanie Wall,2 Kate
Bauer,3 and Dianne Neumark-Sztainer3
1Department of Family Medicine and Community Health,
University of Minnesota Medical School; 2Division of
Biostatistics, University of Minnesota; and 3Division of
Epidemiology and Community Health, University of Minnesota
Background: Family meal frequency, family support for phys-
ical activity, parental modeling, and parenting style have
been linked to healthful dietary behaviors and increased
physical activity among youth. However, previous research
has identified these factors almost in isolation of each other,
and gender influences on these variables have been over-
looked. Therefore, little is known about how these factors co-
occur within families, and the influence of the coexistence of
these factors within families on adolescents’ behavior.
Objective: (1) Use latent class analysis to identify distinct
classes of home environments based on the coexistence of
multiple weight-related family factors. (2) Examine effects of
gender differences between opposite-sex and same-sex par-
ent-child dyads.
Method: Project EAT (Eating Among Teens) data, a popu-
lation-based study (n4746) of adolescents, was used to
identify subtypes of home environments using adolescents’
reporting of characteristics within the home. A latent class
analysis was conducted with 23 measures of the home en-
vironment to identify distinct classes.
Results: Four classes of home environments were identified,
each consisting of distinct combinations of levels of modeling
and encouragement of physical activity and healthy dietary
intake, parenting styles, and family meals habits. Father-
daughter dyads were found to have higher levels of model-
ing and encouraging healthy dietary intake and physical ac-
tivity versus mother-son dyads or same-gender dyads.
Conclusion: Developing home environment classes to un-
derstand how various weight-related factors coexist within
families can provide new insight into the dynamics of the
home environment and the influence of gender on adoles-
cents’ weight-related behaviors.
P-45: Insulin Resistance in Type 1 Diabetes
Correlates With Coronary Artery Calcification
Irene Schauer (presenting author),1,2 Bryan Bergman,1
Janet Snell-Bergeon,3 David M. Maahs,3 Robert H. Eckel1,
and Marian Rewers3
1Division of Endocrinology, Department of Medicine,
University of Colorado, Denver; 2Division of Endocrinology,
Department of Medicine, Denver VA Medical Center; and
3Department of Pediatrics, Barbara Davis Center for Childhood
Diabetes, University of Colorado, Denver
Background: The mechanism of enhanced CVD risk in Type
1 diabetes (T1D) is unclear. Reports have suggested that in-
dividuals with T1D have decreased whole-body insulin sen-
sitivity compared to those without diabetes (non-DM). Less
is known about the antilipolytic effect of insulin or its role
in CVD.
Objective: Measure insulin-mediated non-esterified fatty
acid (NEFA) suppression in T1D and non-DM subjects, and
correlate it to coronary artery calcification (CAC).
Method: As a substudy of the CACTI (CAC in T1D) study,
a three-stage hyperinsulinemic-euglycemic clamp was per-
formed to measure peripheral insulin sensitivity and sup-
pression of NEFA levels in T1D and non-DM subjects.
Results: 54 subjects (39% T1D, 43% male; meanSD:
age436, BMI26.84.3) have been studied. Subjects 
with T1D were whole-body insulin resistant compared to 
non-DM controls (meanSE glucose infusion rate
[mg/kg/min]3.590.85 v. 9.450.65, p0.0001). NEFA
suppression by insulin also differed by T1D status. At
4mU/m2/min of insulin, NEFA levels were suppressed by
39% among controls and increased by 63% in T1D subjects
(p0.0001), indicating adipose tissue insulin resistance (IR)
in T1D. NEFA suppression was also impaired at
8mU/m2/min insulin (11% v. 69%, p0.0001). Total CAC
and CAC progression correlate with whole-body IR
(p0.003, 0.0007) and NEFA levels during clamp stages 1
(p0.05, 0.04) and 2 (p0.01, 0.005).
Conclusion: Subjects with T1D have decreased whole-body
insulin action and insulin-mediated NEFA suppression com-
pared to controls. NEFA levels in response to insulin corre-
late with CAC score and progression. These data suggest a
mechanism by which IR could contribute to CVD risk.
P-46: Quantitative Metabolomics Reveals an 
Epi-Genetic Blueprint for Iron Acquisition in
Uropathogenic Escherichia Coli
Jeffrey P. Henderson (presenting author),1,2 Jan R.
Crowley,2 Jerry S. Pinkner,1,3 Jennifer N. Walker,1,3 Walter
E. Stamm,4 Thomas M. Hooton,5 Scott J. Hultgren1,3
1Center for Women’s Infectious Diseases Research, 2Department
of Internal Medicine, and 3Department of Molecular
Microbiology, Washington University School of Medicine;
4Department of Internal Medicine, University of Washington
School of Medicine; and 5Department of Internal Medicine,
University of Miami Miller School of Medicine
Background: Urinary tract infections (UTIs) caused by uropath-
ogenic E. coli (UPEC) disproportionately affect women and
often recur following treatment. Genetic studies have sug-
gested that the ability to cause UTI correlates with acquisition
or alteration of genes for iron uptake, including those involved
with siderophores—a chemically diverse family of small mol-
ecules that function as iron scavengers.
Objective: To use quantitative product analysis in a patient
population with recurrent UTI to determine if UPEC secrete
a characteristic siderophore profile when compared to coex-
isting rectal strains.
Method: We have developed a novel quantitative meta-
bolomic approach based on stable isotope dilution mass
spectrometry to compare siderophore production between
clinical E. coli isolates. This method was applied to mutant
strains, previously genotyped isolates, and a collection of
PFGE-typed urinary and rectal isolates obtained through a
SCOR collaboration with the University of Washington.
Results: Conventional PCR genotyping was not a reliable
predictor of siderophore production. Differential siderophore
expression between coexisting urinary and rectal E. coli strains
in 13 recurrent UTI patients revealed strong preferential ex-
pression of the siderophores yersiniabactin and salmochelin
by urinary strains. A linearized enterobactin siderophore was
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also newly identified as a product of strains with active
salmochelin genes.
Conclusion: These findings argue that qualititative and
quantitative epigenetic optimization occurs in the E. coli sec-
ondary metabolome among human uropathogens. Because
the virulence-associated biosynthetic pathways are distinct
from those associated with rectal colonization, these results
suggest strategies for virulence-targeted therapies.
P-47: Delayed Referral Does Not Explain Poor
Outcomes in African-American Female Kidney
Transplant Patients
Jennifer McGee (presenting author),1 Tareq M. Islam,2 and
Navyata Mruthinti1
1Department of Surgery, Tulane University School of Medicine;
and 2Department of Epidemiology, Tulane University School of
Public Health
Background and Objective: African Americans (AAs) have
worse graft survival than non-African Americans (NAAs)
following kidney transplantation. A recent analysis from our
center demonstrated that AA women have the greatest risk
for graft failure. Evidence exists that referral rates for black
women are low, but research is limited. The purpose of this
study is to determine if prolonged time to referral explains
poor outcomes in AA female kidney transplant recipients.
Method: Four-hundred and fifty-two patients who under-
went an isolated kidney transplant between January 1996
and December 2004 were included in this retrospective re-
view. Patients were grouped by ethnicity and gender
(AA:NAA male, 135:126; and AA:NAA female, 103:88) and
were followed for up to 3 years for graft failure or death. Pa-
tients receiving a preemptive transplant, a transplant prior
to start of dialysis, were excluded.
Results: Kaplan-Meier estimation identified AA females
having the lowest graft survival at all years, which persisted
after adjustment for age, body mass index, and all other
groups (hazard ratio: 2.6, 95% CI: 1.44, 4.2). Mean duration
of time from diagnosis of end-stage renal disease or first dial-
ysis until the time of transplant evaluation was calculated.
Mean time (years) to evaluation for black women versus all
other groups was 2.32 and 2.4, respectively (p0.83). Multi-
variate adjustment was omitted due to lack of significance.
Conclusion: We speculate that it is largely the AA females
negatively influencing outcomes in AA kidney transplanta-
tion. However, our results suggest that time to referral is not
an impact factor in our population.
P-48: Rising Incidence of End-Stage Renal Disease
(ESRD) Due to Systemic Lupus Erythematosus
Among Blacks and Women
Karen H. Costenbader (presenting author),1 Daniel H.
Solomon,1,2 Wolfgang Winkelmayer,2 M. Alan Brookhart2
Divisions of 1Rheumatology and 2Pharmacoepidemiology,
Department of Medicine, Brigham and Women’s Hospital
Background: Systemic lupus erythematosus (lupus) is an auto-
immune disease that can cause ESRD necessitating dialysis or
renal transplantation. Recent changes in lupus ESRD incidence
in different U.S. sociodemographic groups are unknown.
Objective: We aimed to investigate recent lupus ESRD inci-
dence rates in different sociodemographic groups nationwide.
Method: We examined lupus ESRD incidence rates,
1995–2004, using the U.S. Renal Datasystem, enrolling all
new ESRD patients. We calculated standardized incidence
rates employing U.S. Census population estimates, stratified
according to age, sex, race, and ethnicity.
Results: Lupus ESRD incidence rose from 3.0 to 3.9/million
person-years from 1995 to 2004 in the United States. Women
accounted for 82% of cases; the standardized incidence rate in
women increased from 4.7 to 6.2/million person years. The
37% incidence increase among Blacks (10.5 to 14.4/million per-
son-years) was higher than for other races and ethnicities. The
proportion of Blacks among incident cases increased from 45%
to 49%, exceeding that of Whites, which fell from 47% to 42%.
In 2004, the standard incidence rates (per million person-years)
were 14.4 among Blacks, 4.6 among Hispanics, 3.8 among
Asians and Pacific Islanders, and 2.0 among Whites.
Conclusion: From 1995 to 2004, lupus ESRD incidence rose,
disproportionately so among women and Blacks. For the first
time, the incidence rate in Blacks surpassed that in Whites.
The causes of these alarming disparities deserve further in-
vestigation
P-49: ARFI Ultrasound for Discrimination of
Calcification in Arterial Plaques: Additional
Progress Toward Improved Atherosclerosis
Imaging in Women
Russell Behler, Timothy Nichols, Elizabeth Merricks, and
Caterina Gallippi (presenting author)
University of North Carolina at Chapel Hill
Background: While cardiovascular disease remains the primary
killer of women in Western countries, decreasing death rates
have been attributed to timely and appropriate treatments.
However, treatment administration is limited by shortcomings
in conventional atherosclerosis imaging technologies—they
are not capable of detecting nonstenotic plaques and describ-
ing plaque material composition. These shortcomings may dis-
proportionately impact women, who, recent evidence sug-
gests, are predisposed to developing nonstenotic plaques. We
previously demonstrated that a new imaging technology,
Acoustic Radiation Force Impulse (ARFI) ultrasound, is capa-
ble of detecting nonstenotic plaques and of describing plaque
elastin and collagen composition for risk assessment.
Objective: We now evaluate ARFI’s potential for discrimi-
nating plaque calcium content, which is an established
marker of atheromatous-plaque burden and is predictive of
future risk of cardiovascular events.
Method: Two-dimensional ARFI and matched B-Mode
imaging were performed in the left femoral artery of a fe-
male adult pig in the region of an advanced atherosclerotic
plaque with calcification. The artery was then sectioned for
validation by spatially correlated immunohistochemistry.
Results: In a region of calcium deposition in the context of
diffuse atherosclerosis, median ARFI-induced peak dis-
placement was 20% smaller compared to plaque tissue with
no calcification. Shear Wave Elasticity Imaging (SWEI) de-
rived shear wave velocity was 20% faster in the calcified re-
gion than in the adjacent plaque tissue.
Conclusion: Arterial calcium deposition was associated
with smaller ARFI-induced peak displacement and faster
SWEI-derived shear wave velocities in this pilot investiga-
tion. This supports ARFI’s potential for noninvasive dis-
crimination of arterial calcium content.
P-50: Health Disparities: Obesity, Pre-Diabetes,
and Diabetes Among U.S. Latino, White Non-
Latino, and Black Non-Latino Men and Women
Lorena Garcia
Chicana/Chicano Studies, University of California, Davis
Background: Obesity, diabetes, and metabolic and nutritional
disorders are major public health concerns for morbidity and
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mortality for the Latino population. In the United States the
estimated prevalence for obesity and overweight among 20-
to 75-year-old Latina women is high, 71.9% and 46% re-
spectively.
Objective: The objective of this study is to estimate the
prevalence of obesity, diabetes, and pre-diabetes among a
nationally representative sample of Mexican-American,
White (non-Latina) and Black (non-Latina) women, using the
National Heath and Nutrition Examination Survey
(NHANES) data set.
Method: The data from the NHANES were used to exam-
ine the relationship between obesity, pre-diabetes, and dia-
betes (NCHS 2008b). Data used for this analysis included the
1999–2000, 2001–2002, 2003–2004, and 2005–2006 public use
data files. The NHANES uses a complex probability survey
design and sample weighting methodology.
Results: While more men than women were overweight,
the prevalence of obesity among women was higher than
for men in all three racial/ethnic groups. The prevalence of
pre-diabetes was higher among White non-Latino men
(17.89%) and Latino men (20.95%). In comparison, the
prevalence of diabetes was highest among Black non-Latina
women (5.04%) and White non-Latino males (4.02%), and
similar for Latino men and women (4.56% and 4.41%, re-
spectively).
Conclusion: The results from the NHANES data indicate
gender differences in obesity, overweight, pre-diabetes,
and diabetes among the three racial/ethnic groups studied.
In particular, Black and Latina women had higher preva-
lence of diabetes and obesity. These findings have impor-
tant implications for culturally specific prevention activi-
ties.
P-51: General and Abdominal Adiposity and Risk
of Stroke in Chinese Women
Xianglan Zhang (presenting author),1 Xiao-Ou Shu,1
Yu-Tang Gao,2 Gong Yang,1 Honglan Li,2 Wei Zheng1
1Institute for Medicine and Public Health, Vanderbilt
University School of Medicine; and 2Shanghai Cancer Institute
Background: Although both general and abdominal adipos-
ity are well-established risk factors for coronary heart dis-
ease, their associations with stroke are less well character-
ized, particularly in Asian populations.
Objective: To evaluate the associations of body mass index
(BMI), waist circumference (WC), waist-to-hip ratio (WHR),
and waist-to-height ratio with stroke risk in the Shanghai
Women’s Health Study, an ongoing, population-based,
prospective cohort study of 74,942 Chinese women ages
40–70 at recruitment in 1996–2000.
Method: For this analysis, we included 66,720 women who
reported no prior history of stroke, coronary heart disease,
rheumatic heart disease, cardiac surgery, or cancer, and who
had anthropometric measures taken at recruitment. Incident
cases of stroke were ascertained by biennial home visits and
linkage with the vital statistics.
Results: During a mean followup of 7.3 years, 2,364 strokes
occurred. BMI, WC, WHR, and waist-to-height ratio were all
positively and significantly associated with the risk of total,
ischemic, and hemorrhagic stroke. The multivariable-ad-
justed hazard ratios (95% confidence intervals) for total
stroke comparing the highest v. lowest quintiles of these
measurements were 1.74 (1.51–2.00), 1.80 (1.56–2.09), 1.63
(1.40–1.89), and 1.98 (1.66–2.35) for BMI, WC, WHR, and
waist-to-height ratio, respectively. These positive associa-
tions were attenuated after additional adjustment for poten-
tial biological mediators, especially hypertension. We found
no evidence of effect modification by age, menopausal sta-
tus, exercise, or cigarette smoking.
Conclusion: Both general and abdominal adiposity inde-
pendently predict stroke risk in Chinese women. These data
reinforce the need to incorporate both body weight and fat
distribution measurements in assessing stroke risk.
P-52: Rural African-American Women with Type-2
Diabetes View Motivational Interviewing as Less
Effective Than Traditional Behavioral Counseling
Stephania T. Miller-Hughes
Department of Surgery, Meharry Medical College, 
Vanderbilt University
Background: Motivational interviewing (MI), a patient-cen-
tered method for enhancing a patient’s motivation for be-
havioral change, has been the main intervention strategy in
many studies to improve behavioral and health outcomes of
patients with type-2 diabetes. The success of such interven-
tions is highly dependent on patient acceptance of MI prin-
ciples and strategies. However, little research has assessed
patients’ perceptions of MI prior to intervention implemen-
tation.
Objective: This study evaluated MI perceptions among
rural African American women with type-2 diabetes.
Method: Four moderator-led focus groups were conducted
with patients ages 21–50 who had never participated in an
MI-focused behavioral intervention. Patients were asked to
share general perceptions and perceived advantages and dis-
advantages of MI after viewing a patient/healthcare
provider MI consultation; from a DVD series entitled Moti-
vational Interviewing: Professional Training Series. Content-
based data analysis of focus group transcripts was conducted
using qualitative data analysis software, Atlas.ti., and ana-
lyst coding.
Results: Thirty patients participated. Two themes de-
scribed perceived advantages of MI: (1) good communica-
tion and (2) active patient involvement. The patient-cen-
teredness of the consultation was the single theme that
described perceived disadvantages. Correspondingly, com-
pared to MI, patients agreed that physician-led interactions
(i.e., physician-led goal setting, limited patient input) were
more representative of “good counseling” and also were
most familiar to them.
Conclusion: These findings suggest that patients have both
negative and positive views of MI. Future studies should as-
sess whether patient satisfaction with MI interventions in-
fluences study protocol adherence and behavioral and health
outcomes.
P-53: Female Obesity and Utilization of 
Fertility-Related Services
Anjel Vahratian
Department of Obstetrics and Gynecology, University 
of Michigan
Background: The increasing prevalence of obesity is a criti-
cal public health problem for women of childbearing age,
as obesity can impair a woman’s ability to conceive and in-
crease her risk for an adverse pregnancy outcome. Yet,
there is a paucity of information on whether utilization of
fertility-related services varies according to female body
mass.
Objective: To assess the relationship between female body
mass index (BMI) and the utilization of fertility-related care
in the United States.
Method: Data from the 2002 National Survey of Family
Growth were examined to compute percentages for various
fertility-related services, stratified by BMI categories.
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Results: Obese women (11.5%) were more likely than un-
derweight/normal (9.5%) and overweight (8.7%) women to
report that they (or their partner) ever received fertility-re-
lated services. Advice, infertility testing, and drugs to im-
prove ovulation were the most common services received
across BMI categories. When infertility testing was per-
formed, 31% of obese women reported that they alone un-
derwent testing, compared to 18% of overweight women and
25% of underweight/normal women. The proportion of
women who underwent artificial insemination varied from
12% in obese women to 16% in overweight women. “Prob-
lems with ovulation” was the most frequently reported di-
agnosis across the BMI categories, especially among obese
women (44%).
Conclusion: Subtle differences exist in the utilization of fer-
tility-related services according to female body mass; how-
ever, these disparities do not appear to be as consistent with
increasing BMI.
P-54: Obesity and Women’s Fertility Over 
the Life Course
Michelle L. Frisco (presenting author),1 Margaret Weden,2
and Kristin Burnett1
1Department of Sociology, The Pennsylvania State University;
and 2The RAND Corporation
Background: Obesity is one of the most serious public health
problems facing women today. This indicator of health sta-
tus has important biological and social components, which
has led scientists across disciplines to demonstrate obesity’s
links to the proximate determinants of fertility. As such, the
negative consequences of obesity may accumulate over the
life course leading obese young women to be stratified into
disadvantaged positions for childbearing.
Objective: This study asks whether obesity is associated
with young women’s life course fertility experiences. The au-
thors hypothesize that compared to their non-obese coun-
terparts, obese young women have fewer live births, a higher
risk of remaining childless, and later timing of first birth.
Method: Twenty-three years of data from National Longi-
tudinal Survey of Youth: 1979 (NLSY:79) female respondents
ages 20–24 in 1981 are analyzed to test these hypotheses us-
ing descriptive statistics, logistic regression methods, and
event history analyses.
Results: All hypotheses are supported. On average, obese
women have fewer children than non-obese women. Fur-
thermore, compared to normal weight women, obese
women’s odds of remaining childless are almost three times
as high after models include confounders. Obese women’s
lower parity may be explained by their later timing of first
birth. Their hazard of first birth is over two times lower than
normal weight peers after statistical models account for con-
founders.
Conclusion: Results confirm obese young women’s position
of disadvantage for childbearing and show that the negative
consequences of obesity accumulate across a life domain that
is incredibly important for the vast majority of American
women.
P-55: Birth Size and Adult Metabolic Syndrome:
Interaction With Race and Sex
Emily Harville (presenting author), Wei Chen, and Gerald
Berenson
Tulane University, School of Public Health
Background: Fetal growth retardation has been associated
with the adult development of metabolic syndrome (MS).
Some studies also suggest that high birthweight is also as-
sociated with higher risk.
Objective: To examine the associations between birth size
and metabolic syndrome, including interaction by race and
sex
Method: Birth certificate data were linked to records of par-
ticipants in the Bogalusa Heart Study. Metabolic syndrome
was defined by the National Cholesterol Education Program
definition. Low birthweight was defined as birth-
weight2500 g; macrosomia as birthweight 4000 g; SGA
as birthweight 10th percentile for gestational age; and LGA
as birthweight 90th percentile for gestational age. Logistic
regression was used to adjust for smoking, alcohol use, in-
come, home ownership, parental education, age, race, and
sex.
Results: No association was seen between birth factors and
MS (adjusted odds ratio [OR] for LBW 1.17, 95% confidence
interval [CI] 0.61–2.24; for macrosomia, 0.80, 0.46–1.39; for
SGA, 1.34, 0.76–2.38; for LGA, 0.96, 0.62–1.49). No interac-
tion was seen with race. The risk associated with being small
at birth was generally stronger for men than women; how-
ever, associations were imprecise. However, being too large
was associated with an increased risk of MS for men (LGA,
1.54, 0.80–2.98), but a decreased risk for women (0.70,
0.39–1.26).
Conclusion: In this cohort, the relationship between both
high and low birthweight and MS was not seen. The rela-
tionship between birthweight and MS may be stronger in
men than women.
P-56: Gender Differences in BMI and 
Health-Related Quality of Life Among Older
Mexican Americans
Soham Al Snih (presenting author) ,1,2 James E. Graham,1
and Kenneth J. Ottenbacher1,2
1Division of Rehabilitation Sciences, and 2Sealy Center on
Aging, The University of Texas Medical Branch at Galveston
Background: Obesity is a major health problem associated
with morbidity, disability, and reduced quality of life.
Objective: Examine gender differences between body mass
index (BMI) and health-related quality of life (HRQoL) in
Mexican-American older adults. Also, examine the mediat-
ing effect of physical function and medical conditions on the
association between obesity and HRQoL.
Method: Cross-sectional study of 830 Mexican-American
men and women aged 75 residing in five southwestern
States in the United States. Data were collected on sociode-
mographic variables, physical function, medical conditions,
BMI, and the Medical Outcomes Study Short Form Health
Survey (SF-36).
Results: Out of 830 subjects, 28.6% of women and 19.7% of
men had a BMI30 kg/m2. Mean score for the Physical
Composite Scale (PCS) of the SF-36 was 34.24 (SD11.33) in
obese women and 41.32 (SD10.4) in obese men. In a mul-
tiple regression analysis, an interaction effect between gen-
der and BMI on the PCS was found (-0.38, p0.001). Anal-
ysis by gender found that high BMI (30 kg/m2) in women
was significantly associated with lower scores on the PCS,
while in men was not significantly associated with the PCS.
The association between BMI30 kg/m2 and the PCS in
women was partially mediated by physical function and
medical conditions. No significant association was found be-
tween high BMI and the Mental Composite Scale (MCS) of
the SF-36 in men or women.
Conclusion: High BMI was associated with lower HRQoL
in older Mexican-American women. No association was
found between high BMI and HRQoL in men.
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P-57: Gender Differences in Mortality Among
Older Frail Mexican Americans
Ivonne-Marie Berges (presenting author),1 James E.
Graham,1 Glenn V. Ostir,2 Kyriakos S. Markides,3
and J. Ottenbacher1
1Rehabilitation Sciences, 2Internal Medicine, and 3Preventive
Medicine and Community Health, University of Texas 
Medical Branch
Objective: To examine the association between frailty and 10-
year mortality among older men and women of Mexican-
American origin.
Method: Data were collected from 1995/1996 to 2004/2005
among community-dwelling Mexican Americans 65 years
and older as part of the Hispanic Established Population for
the Epidemiologic Study of the Elderly. A standardized
frailty index based on weight loss, exhaustion, grip strength,
walking speed, and physical activity was computed. Data
were collected on sociodemographics and health character-
istics, comorbidities, and performance-based functional mea-
sure.
Results: The sample was 58% female and mean baseline
age was 74.5 years (SD6.06) at baseline. Hazard ratios (HR)
indicated an increased mortality risk in frail men (HR3.04,
95% CI 2.16, 4.28) compared to frail women (HR1.92, 95%
CI 1.39, 2.65).
Conclusion: Frailty is an independent predictor of mortal-
ity among older men and women of Mexican-American ori-
gin. This association was found to be stronger among men. 
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